: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

COVID-19

Free Subscription

Articles published in J Virol
Retrieve available abstracts of 415 articles:
HTML format

Single Articles

April 2024

HAN Y, Yuan Z, Yi Z
Identification of a membrane-associated element (MAE) in the C-terminal region of SARS-CoV-2 nsp6 that is essential for viral replication.
J Virol. 2024 Apr 19:e0034924. doi: 10.1128/jvi.00349.
PubMed Abstract available

PEREZ DR
A devastating blow: personal reflections on Argentina's scientific decline.
J Virol. 2024 Apr 16:e0054924. doi: 10.1128/jvi.00549.
PubMed Abstract available

ISHIMARU H, Nishimura M, Shigematsu H, Marini MI, et al
Epitopes of an antibody that neutralizes a wide range of SARS-CoV-2 variants in a conserved subdomain 1 of the spike protein.
J Virol. 2024 Apr 16:e0041624. doi: 10.1128/jvi.00416.
PubMed Abstract available

WANG X, Qiu W, Hu G, Diao X, et al
NS7a of SADS-CoV promotes viral infection via inducing apoptosis to suppress type III interferon production.
J Virol. 2024 Apr 16:e0031724. doi: 10.1128/jvi.00317.
PubMed Abstract available

TAKADA K, Orba Y, Kida Y, Wu J, et al
Genes involved in the limited spread of SARS-CoV-2 in the lower respiratory airways of hamsters may be associated with adaptive evolution.
J Virol. 2024 Apr 16:e0178423. doi: 10.1128/jvi.01784.
PubMed Abstract available

EBRIGHT RH, MacIntyre R, Dudley JP, Butler CD, et al
Implementing governmental oversight of enhanced potential pandemic pathogen research.
J Virol. 2024;98:e0023724.
PubMed

BOON ACM, Bricker TL, Fritch EJ, Leist SR, et al
Efficacy of host cell serine protease inhibitor MM3122 against SARS-CoV-2 for treatment and prevention of COVID-19.
J Virol. 2024 Apr 9:e0190323. doi: 10.1128/jvi.01903.
PubMed Abstract available

ZHOU J, Sun P, Wang Y, Qiu R, et al
Deep profiling of potential substrate atlas of porcine epidemic diarrhea virus 3C-like protease.
J Virol. 2024 Apr 9:e0025324. doi: 10.1128/jvi.00253.
PubMed Abstract available

YANG R, Han P, Han P, Li D, et al
Molecular basis of hippopotamus ACE2 binding to SARS-CoV-2.
J Virol. 2024 Apr 9:e0045124. doi: 10.1128/jvi.00451.
PubMed Abstract available

XIAO X, Fu Y, You W, Huang C, et al
Inhibition of the RLR signaling pathway by SARS-CoV-2 ORF7b is mediated by MAVS and abrogated by ORF7b-homologous interfering peptide.
J Virol. 2024 Apr 4:e0157323. doi: 10.1128/jvi.01573.
PubMed Abstract available

BRUNET J, Choucha Z, Gransagne M, Tabbal H, et al
A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: candidate selection in a preclinical murine model.
J Virol. 2024 Apr 2:e0169323. doi: 10.1128/jvi.01693.
PubMed Abstract available

NAMBULLI S, Escriou N, Rennick LJ, Demers MJ, et al
A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: protection of African green monkeys from COVID-19 disease.
J Virol. 2024 Apr 2:e0176223. doi: 10.1128/jvi.01762.
PubMed Abstract available

ZHU Z, Han Y, Gong M, Sun B, et al
Establishment of replication-competent vesicular stomatitis virus recapitulating SADS-CoV entry.
J Virol. 2024 Apr 1:e0195723. doi: 10.1128/jvi.01957.
PubMed Abstract available

March 2024

YANG Y-L, Wang B, Li W, Cai H-L, et al
Functional dissection of the spike glycoprotein S1 subunit and identification of cellular cofactors for regulation of swine acute diarrhea syndrome coronavirus entry.
J Virol. 2024 Mar 19:e0013924. doi: 10.1128/jvi.00139.
PubMed Abstract available

MAI F, Bergmann W, Reisinger EC, Muller-Hilke B, et al
The varying extent of humoral and cellular immune responses to either vector- or RNA-based SARS-CoV-2 vaccines persists for at least 18 months and is independent of infection.
J Virol. 2024 Mar 19:e0191223. doi: 10.1128/jvi.01912.
PubMed Abstract available

WANG T, Hu L, Li R, Ren H, et al
Hyperoside inhibits EHV-8 infection via alleviating oxidative stress and IFN production through activating JNK/Keap1/Nrf2/HO-1 signaling pathways.
J Virol. 2024 Mar 19:e0015924. doi: 10.1128/jvi.00159.
PubMed Abstract available

WANG X, Tong W, Yang X, Zhai H, et al
RBM14 inhibits the replication of porcine epidemic diarrhea virus by recruiting p62 to degrade nucleocapsid protein through the activation of autophagy and interferon pathway.
J Virol. 2024;98:e0018224.
PubMed Abstract available

LIU D, Cruz-Cosme R, Wu Y, Leibowitz J, et al
2-Bromopalmitate depletes lipid droplets to inhibit viral replication.
J Virol. 2024 Mar 15:e0017124. doi: 10.1128/jvi.00171.
PubMed Abstract available

BABOT M, Boulard Y, Agouda S, Pieri L, et al
Oligomeric assembly of the C-terminal and transmembrane region of SARS-CoV-2 nsp3.
J Virol. 2024 Mar 14:e0157523. doi: 10.1128/jvi.01575.
PubMed Abstract available

HEINDL MR, Rupp A-L, Schwerdtner M, Bestle D, et al
ACE2 acts as a novel regulator of TMPRSS2-catalyzed proteolytic activation of influenza A virus in airway cells.
J Virol. 2024 Mar 12:e0010224. doi: 10.1128/jvi.00102.
PubMed Abstract available

ZHENG T, Shen B, Bai Y, Li E, et al
The PKA-CREB1 axis regulates coronavirus proliferation by viral helicase nsp13 association.
J Virol. 2024 Mar 6:e0156523. doi: 10.1128/jvi.01565.
PubMed Abstract available

February 2024

MARTINS M, Nooruzzaman M, Cunningham JL, Ye C, et al
The SARS-CoV-2 Spike is a virulence determinant and plays a major role on the attenuated phenotype of Omicron virus in a feline model of infection.
J Virol. 2024 Feb 29:e0190223. doi: 10.1128/jvi.01902.
PubMed Abstract available

HE H, Li Y, Chen Y, Chen J, et al
NLRP1 restricts porcine deltacoronavirus infection via IL-11 inhibiting the phosphorylation of the ERK signaling pathway.
J Virol. 2024 Feb 27:e0198223. doi: 10.1128/jvi.01982.
PubMed Abstract available

HUANG H, Lei X, Zhao C, Qin Y, et al
Porcine deltacoronavirus nsp5 antagonizes type I interferon signaling by cleaving IFIT3.
J Virol. 2024;98:e0168223.
PubMed Abstract available

STOLL GA, Nikolopoulos N, Zhai H, Zhang L, et al
Crystal structure and biochemical activity of the macrodomain from rubella virus p150.
J Virol. 2024;98:e0177723.
PubMed Abstract available

LI Z, Lai Y, Qiu R, Tang W, et al
Hyperacetylated microtubules assist porcine deltacoronavirus nsp8 to degrade MDA5 via SQSTM1/p62-dependent selective autophagy.
J Virol. 2024 Feb 14:e0000324. doi: 10.1128/jvi.00003.
PubMed Abstract available

VANSLAMBROUCK JM, Neil JA, Rudraraju R, Mah S, et al
Kidney organoids reveal redundancy in viral entry pathways during ACE2-dependent SARS-CoV-2 infection.
J Virol. 2024 Feb 9:e0180223. doi: 10.1128/jvi.01802.
PubMed Abstract available

BRICKER TL, Joshi A, Soudani N, Scheaffer SM, et al
Prototype and BA.5 protein nanoparticle vaccines protect against Omicron BA.5 variant in Syrian hamsters.
J Virol. 2024 Feb 2:e0120623. doi: 10.1128/jvi.01206.
PubMed Abstract available

NIU S, Zhao Z, Liu Z, Rong X, et al
Structural basis and analysis of hamster ACE2 binding to different SARS-CoV-2 spike RBDs.
J Virol. 2024 Feb 2:e0115723. doi: 10.1128/jvi.01157.
PubMed Abstract available

HSIEH M-S, Hsu C-W, Liao H-C, Lin C-L, et al
SARS-CoV-2 spike-FLIPr fusion protein plus lipidated FLIPr protects against various SARS-CoV-2 variants in hamsters.
J Virol. 2024 Feb 1:e0154623. doi: 10.1128/jvi.01546.
PubMed Abstract available

ZHANG X-Z, Wang J, Tian W-J, You J-L, et al
Phospho-eIF4E stimulation regulates coronavirus entry by selective expression of cell membrane-residential factors.
J Virol. 2024 Feb 1:e0194823. doi: 10.1128/jvi.01948.
PubMed Abstract available

January 2024

SHEN S, Guo H, Li Y, Zhang L, et al
SARS-CoV-2 and oncolytic EV-D68-encoded proteases differentially regulate pyroptosis.
J Virol. 2024 Jan 30:e0190923. doi: 10.1128/jvi.01909.
PubMed Abstract available

LI Z, Xiao W, Yang Z, Guo J, et al
Cleavage of HDAC6 to dampen its antiviral activity by nsp5 is a common strategy of swine enteric coronaviruses.
J Virol. 2024 Jan 30:e0181423. doi: 10.1128/jvi.01814.
PubMed Abstract available

ZHANG S, Wang J, Liu X, Kan Z, et al
Pemetrexed alleviates piglet diarrhea by blocking the interaction between porcine epidemic diarrhea virus nucleocapsid protein and Ezrin.
J Virol. 2024;98:e0162523.
PubMed Abstract available

SCHMIED K, Ehmann R, Kristen-Burmann C, Ebert N, et al
An RNA replicon system to investigate promising inhibitors of feline coronavirus.
J Virol. 2024 Jan 18:e0121623. doi: 10.1128/jvi.01216.
PubMed Abstract available

DULIN H, Barre RS, Xu D, Neal A, et al
Harnessing preexisting influenza virus-specific immunity increases antibody responses against SARS-CoV-2.
J Virol. 2024 Jan 11:e0157123. doi: 10.1128/jvi.01571.
PubMed Abstract available

BERTZBACH LD, Seddar L, von Stromberg K, Ip W-H, et al
The adenovirus DNA-binding protein DBP.
J Virol. 2024 Jan 10:e0188523. doi: 10.1128/jvi.01885.
PubMed Abstract available

YIN L, Liu X, Yao Y, Yuan M, et al
Gut microbiota-derived butyrate promotes coronavirus TGEV infection through impairing RIG-I-triggered local type I interferon responses via class I HDAC inhibition.
J Virol. 2024 Jan 10:e0137723. doi: 10.1128/jvi.01377.
PubMed Abstract available

FARJO M, Koelle K, Martin MA, Gibson LL, et al
Within-host evolutionary dynamics and tissue compartmentalization during acute SARS-CoV-2 infection.
J Virol. 2024 Jan 4:e0161823. doi: 10.1128/jvi.01618.
PubMed Abstract available

DEY S, Mondal A
Unveiling the role of host kinases at different steps of influenza A virus life cycle.
J Virol. 2024 Jan 4:e0119223. doi: 10.1128/jvi.01192.
PubMed Abstract available

LI K, Verma A, Li P, Ortiz ME, et al
Adaptation of SARS-CoV-2 to ACE2(H353K) mice reveals new spike residues that drive mouse infection.
J Virol. 2024 Jan 3:e0151023. doi: 10.1128/jvi.01510.
PubMed Abstract available

RASMUSSEN AL, Gronvall GK, Lowen AC, Goodrum F, et al
Virology-the path forward.
J Virol. 2024 Jan 3:e0179123. doi: 10.1128/jvi.01791.
PubMed Abstract available

December 2023

GAO Q, Weng Z, Feng Y, Gong T, et al
KPNA2 suppresses porcine epidemic diarrhea virus replication by targeting and degrading virus envelope protein through selective autophagy.
J Virol. 2023;97:e0011523.
PubMed Abstract available

FU Z, Xiang Y, Fu Y, Su Z, et al
DYRK1A is a multifunctional host factor that regulates coronavirus replication in a kinase-independent manner.
J Virol. 2023 Dec 15:e0123923. doi: 10.1128/jvi.01239.
PubMed Abstract available

BOLLAND W, Michel V, Planas D, Hubert M, et al
High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1.
J Virol. 2023 Dec 13:e0135123. doi: 10.1128/jvi.01351.
PubMed Abstract available

JERONIMO PMC, Aksenen CF, Duarte IO, Lins RD, et al
Evolutionary deletions within the SARS-CoV-2 genome as signature trends for virus fitness and adaptation.
J Virol. 2023 Dec 13:e0140423. doi: 10.1128/jvi.01404.
PubMed Abstract available

GAO W, Wang L, Cui W, Wang H, et al
Deubiquitinase USP1 regulates sarbecovirus ORF6 protein function.
J Virol. 2023 Dec 12:e0143723. doi: 10.1128/jvi.01437.
PubMed Abstract available

PHAM TX, Huynh TTX, Choi J, Lee J-B, et al
SARS-CoV-2 exploits cellular RAD51 to promote viral propagation: implication of RAD51 inhibitor as a potential drug candidate against COVID-19.
J Virol. 2023 Dec 5:e0173723. doi: 10.1128/jvi.01737.
PubMed Abstract available

ZAYOU L, Prakash S, Dhanushkodi NR, Quadiri A, et al
A multi-epitope/CXCL11 prime/pull coronavirus mucosal vaccine boosts the frequency and the function of lung-resident memory CD4(+) and CD8(+) T cells and enhanced protection against COVID-19-like symptoms and death caused by SARS-CoV-2 infection.
J Virol. 2023 Dec 1:e0109623. doi: 10.1128/jvi.01096.
PubMed Abstract available

SO RTY, Chu DKW, Hui KPY, Mok CKP, et al
Amino acid substitution L232F in non-structural protein 6 identified as a possible human-adaptive mutation in clade B MERS coronaviruses.
J Virol. 2023 Dec 1:e0136923. doi: 10.1128/jvi.01369.
PubMed Abstract available

November 2023

NARAYANAN KK, Amaya M, Tsang N, Yin R, et al
Sequence basis for selectivity of ephrin-B2 ligand for Eph receptors and pathogenic henipavirus G glycoproteins.
J Virol. 2023;97:e0062123.
PubMed Abstract available

LI K, Huntwork RHC, Horn GQ, Abraha M, et al
Cryptic-site-specific antibodies to the SARS-CoV-2 receptor binding domain can retain functional binding affinity to spike variants.
J Virol. 2023 Nov 29:e0107023. doi: 10.1128/jvi.01070.
PubMed Abstract available

YANG S, Huang X, Li S, Wang C, et al
Linoleic acid: a natural feed compound against porcine epidemic diarrhea disease.
J Virol. 2023 Nov 27:e0170023. doi: 10.1128/jvi.01700.
PubMed Abstract available

WANG Z, He W, Li C, Chen Y, et al
The role of lysosomes as intermediates in betacoronavirus PHEV egress from nerve cells.
J Virol. 2023 Nov 27:e0133823. doi: 10.1128/jvi.01338.
PubMed Abstract available

DOMINGO E, Martinez-Gonzalez B, Garcia-Crespo C, Somovilla P, et al
Puzzles, challenges, and information reservoir of SARS-CoV-2 quasispecies.
J Virol. 2023 Nov 21:e0151123. doi: 10.1128/jvi.01511.
PubMed Abstract available

BRAGAZZI CUNHA J, Leix K, Sherman EJ, Mirabelli C, et al
Type I interferon signaling induces a delayed antiproliferative response in respiratory epithelial cells during SARS-CoV-2 infection.
J Virol. 2023 Nov 17:e0127623. doi: 10.1128/jvi.01276.
PubMed Abstract available

NIU X, Liu M, Yang S, Xu J, et al
A recombination-resistant genome for live attenuated and stable PEDV vaccines by engineering the transcriptional regulatory sequences.
J Virol. 2023 Nov 16:e0119323. doi: 10.1128/jvi.01193.
PubMed Abstract available

ALRUWAILI M, Armstrong S, Prince T, Erdmann M, et al
SARS-CoV-2 NSP12 associates with TRiC and the P323L substitution acts as a host adaption.
J Virol. 2023 Nov 6:e0042423. doi: 10.1128/jvi.00424.
PubMed Abstract available

October 2023

PAHMEIER F, Lavacca T-M, Goellner S, Neufeldt CJ, et al
Identification of host dependency factors involved in SARS-CoV-2 replication organelle formation through proteomics and ultrastructural analysis.
J Virol. 2023 Oct 31:e0087823. doi: 10.1128/jvi.00878.
PubMed Abstract available

YANG X, Kong N, Qin W, Zhai X, et al
PGAM5 degrades PDCoV N protein and activates type I interferon to antagonize viral replication.
J Virol. 2023 Oct 26:e0147023. doi: 10.1128/jvi.01470.
PubMed Abstract available

OLARTE-CASTILLO XA, Plimpton L, McQueary H, Sun Y, et al
Detection and characterization of novel luchacoviruses, genus Alphacoronavirus, in saliva and feces of meso-carnivores in the northeastern United States.
J Virol. 2023 Oct 26:e0082923. doi: 10.1128/jvi.00829.
PubMed Abstract available

UNDI RB, Ahsan N, Larabee JL, Darlene-Reuter N, et al
Blocking of doublecortin-like kinase 1-regulated SARS-CoV-2 replication cycle restores cell signaling network.
J Virol. 2023 Oct 20:e0119423. doi: 10.1128/jvi.01194.
PubMed Abstract available

KUMAR S, Delipan R, Chakraborty D, Kanjo K, et al
Mutations in S2 subunit of SARS-CoV-2 Omicron spike strongly influence its conformation, fusogenicity, and neutralization sensitivity.
J Virol. 2023 Oct 20:e0092223. doi: 10.1128/jvi.00922.
PubMed Abstract available

YE G, Pan R, Bu F, Zheng J, et al
Discovery of Nanosota-2, -3, and -4 as super potent and broad-spectrum therapeutic nanobody candidates against COVID-19.
J Virol. 2023 Oct 19:e0144823. doi: 10.1128/jvi.01448.
PubMed Abstract available

SUN H, Wang Y, Chen X, Jiang Y, et al
Structural basis for broad neutralization of human antibody against Omicron sublineages and evasion by XBB variant.
J Virol. 2023 Oct 19:e0113723. doi: 10.1128/jvi.01137.
PubMed Abstract available

JOHNSON RM, Ardanuy J, Hammond H, Logue J, et al
Diet-induced obesity and diabetes enhance mortality and reduce vaccine efficacy for SARS-CoV-2.
J Virol. 2023 Oct 17:e0133623. doi: 10.1128/jvi.01336.
PubMed Abstract available

LI J, Zhao S, Zhang B, Huang J, et al
A novel recombinant S-based subunit vaccine induces protective immunity against porcine deltacoronavirus challenge in piglets.
J Virol. 2023 Oct 17:e0095823. doi: 10.1128/jvi.00958.
PubMed Abstract available

GAO J, Tang YD, Hu W, Zheng C, et al
Correction for Gao et al., "When Poly(A) Binding Proteins Meet Viral Infections, Including SARS-CoV-2".
J Virol. 2023 Oct 16:e0098523. doi: 10.1128/jvi.00985.
PubMed

WU Y, Shi J, He X, Lu J, et al
Protection of the receptor binding domain (RBD) dimer against SARS-CoV-2 and its variants.
J Virol. 2023 Oct 16:e0127923. doi: 10.1128/jvi.01279.
PubMed Abstract available

SUO X, Wang J, Wang D, Fan G, et al
DHA and EPA inhibit porcine coronavirus replication by alleviating ER stress.
J Virol. 2023 Oct 16:e0120923. doi: 10.1128/jvi.01209.
PubMed Abstract available

MIURA K, Suzuki Y, Ishida K, Arakawa M, et al
Distinct motifs in the E protein are required for SARS-CoV-2 virus particle formation and lysosomal deacidification in host cells.
J Virol. 2023 Oct 13:e0042623. doi: 10.1128/jvi.00426.
PubMed Abstract available

MAHE D, Bourgeau S, da Silva J, Schlederer J, et al
SARS-CoV-2 replicates in the human testis with slow kinetics and has no major deleterious effects ex vivo.
J Virol. 2023 Oct 13:e0110423. doi: 10.1128/jvi.01104.
PubMed Abstract available

RIBO-MOLINA P, Weiss HJ, Susma B, van Nieuwkoop S, et al
4-Octyl itaconate reduces influenza A replication by targeting the nuclear export protein CRM1.
J Virol. 2023 Oct 12:e0132523. doi: 10.1128/jvi.01325.
PubMed Abstract available

FANG P, Zhang H, Cheng T, Ding T, et al
Porcine deltacoronavirus accessory protein NS6 harnesses VPS35-mediated retrograde trafficking to facilitate efficient viral infection.
J Virol. 2023 Oct 10:e0095723. doi: 10.1128/jvi.00957.
PubMed Abstract available

MCMAHON M, Tan J, O'Dell G, Kirkpatrick Roubidoux E, et al
Immunity induced by vaccination with recombinant influenza B virus neuraminidase protein breaks viral transmission chains in guinea pigs in an exposure intensity-dependent manner.
J Virol. 2023 Oct 6:e0105723. doi: 10.1128/jvi.01057.
PubMed Abstract available

KIMURA I, Yamasoba D, Nasser H, Ito H, et al
Multiple mutations of SARS-CoV-2 Omicron BA.2 variant orchestrate its virological characteristics.
J Virol. 2023 Oct 5:e0101123. doi: 10.1128/jvi.01011.
PubMed Abstract available

September 2023

CHEN Y, Liu X, Zheng JN, Yang LJ, et al
N-linked glycoproteins and host proteases are involved in swine acute diarrhea syndrome coronavirus entry.
J Virol. 2023 Sep 29:e0091623. doi: 10.1128/jvi.00916.
PubMed Abstract available

ZHAO Y, Sui L, Wu P, Li L, et al
EGR1 functions as a new host restriction factor for SARS-CoV-2 to inhibit virus replication through the E3 ubiquitin ligase MARCH8.
J Virol. 2023 Sep 29:e0102823. doi: 10.1128/jvi.01028.
PubMed Abstract available

LI J, Gui Q, Liang FX, Sall J, et al
The REEP5/TRAM1 complex binds SARS-CoV-2 NSP3 and promotes virus replication.
J Virol. 2023 Sep 28:e0050723. doi: 10.1128/jvi.00507.
PubMed Abstract available

PENG Q, Fan B, Song X, He W, et al
Genetic signatures associated with the virulence of porcine epidemic diarrhea virus AH2012/12.
J Virol. 2023 Sep 21:e0106323. doi: 10.1128/jvi.01063.
PubMed Abstract available

SCHOEN A, Holzer M, Muller MA, Wallerang KB, et al
Functional comparisons of the virus sensor RIG-I from humans, the microbat Myotis daubentonii, and the megabat Rousettus aegyptiacus, and their response to SARS-CoV-2 infection.
J Virol. 2023 Sep 20:e0020523. doi: 10.1128/jvi.00205.
PubMed Abstract available

FUJITA S, Kosugi Y, Kimura I, Tokunaga K, et al
Determination of the factors responsible for the tropism of SARS-CoV-2-related bat coronaviruses to Rhinolophus bat ACE2.
J Virol. 2023 Sep 19:e0099023. doi: 10.1128/jvi.00990.
PubMed Abstract available

KRCHLIKOVA V, Lotke R, Haussmann I, Reinisova M, et al
Independent loss events of a functional tetherin gene in galliform birds.
J Virol. 2023 Sep 15:e0080323. doi: 10.1128/jvi.00803.
PubMed Abstract available

XING M, Wang Y, Wang X, Liu J, et al
Broad-spectrum vaccine via combined immunization routes triggers potent immunity to SARS-CoV-2 and its variants.
J Virol. 2023 Sep 14:e0072423. doi: 10.1128/jvi.00724.
PubMed Abstract available

DAHAL S, Clayton K, Cabral T, Cheng R, et al
On a path toward a broad-spectrum anti-viral: inhibition of HIV-1 and coronavirus replication by SR kinase inhibitor harmine.
J Virol. 2023 Sep 14:e0039623. doi: 10.1128/jvi.00396.
PubMed Abstract available

KERR CM, Parthasarathy S, Schwarting N, O'Connor JJ, et al
PARP12 is required to repress the replication of a Mac1 mutant coronavirus in a cell- and tissue-specific manner.
J Virol. 2023 Sep 11:e0088523. doi: 10.1128/jvi.00885.
PubMed Abstract available

LI Z, Ma Z, Han W, Chang C, et al
Deletion of a 7-amino-acid region in the porcine epidemic diarrhea virus envelope protein induces higher type I and III interferon responses and results in attenuation in vivo.
J Virol. 2023 Sep 8:e0084723. doi: 10.1128/jvi.00847.
PubMed Abstract available

HAN P, Meng Y, Zhang D, Xu Z, et al
Structural basis of white-tailed deer, Odocoileus virginianus, ACE2 recognizing all the SARS-CoV-2 variants of concern with high affinity.
J Virol. 2023 Sep 7:e0050523. doi: 10.1128/jvi.00505.
PubMed Abstract available

CASE JB, Scheaffer SM, Darling TL, Bricker TL, et al
Characterization of the SARS-CoV-2 BA.5.5 and BQ.1.1 Omicron variants in mice and hamsters.
J Virol. 2023 Sep 7:e0062823. doi: 10.1128/jvi.00628.
PubMed Abstract available

LIU Y, Chen D, Wang Y, Li X, et al
Characterization of CCoV-HuPn-2018 spike protein-mediated viral entry.
J Virol. 2023 Sep 7:e0060123. doi: 10.1128/jvi.00601.
PubMed Abstract available

DANIELS A, Fletcher S, Kerr HEM, Kratzel A, et al
One for all-human kidney Caki-1 cells are highly susceptible to infection with corona- and other respiratory viruses.
J Virol. 2023 Sep 5:e0055523. doi: 10.1128/jvi.00555.
PubMed Abstract available

GUO H, Li A, Dong TY, Si HR, et al
Isolation of ACE2-dependent and -independent sarbecoviruses from Chinese horseshoe bats.
J Virol. 2023 Sep 1:e0039523. doi: 10.1128/jvi.00395.
PubMed Abstract available

August 2023

LIN HF, Liu MQ, Jiang RD, Gong QC, et al
Characterization of a mouse-adapted strain of bat severe acute respiratory syndrome-related coronavirus.
J Virol. 2023 Aug 21:e0079023. doi: 10.1128/jvi.00790.
PubMed Abstract available

LEONARD RA, Rao VN, Bartlett A, Froggatt HM, et al
A low-background, fluorescent assay to evaluate inhibitors of diverse viral proteases.
J Virol. 2023 Aug 14:e0059723. doi: 10.1128/jvi.00597.
PubMed Abstract available

JIN H, Cheng L, Gong Y, Zhu Y, et al
Design of a bifunctional pan-sarbecovirus entry inhibitor targeting the cell receptor and viral fusion protein.
J Virol. 2023 Aug 14:e0019223. doi: 10.1128/jvi.00192.
PubMed Abstract available

ZHANG W, Shi K, Geng Q, Herbst M, et al
Structural evolution of SARS-CoV-2 omicron in human receptor recognition.
J Virol. 2023 Aug 14:e0082223. doi: 10.1128/jvi.00822.
PubMed Abstract available

LLEWELLYN GN, Chen HY, Rogers GL, Huang X, et al
Comparison of SARS-CoV-2 entry inhibitors based on ACE2 receptor or engineered Spike-binding peptides.
J Virol. 2023 Aug 9:e0068423. doi: 10.1128/jvi.00684.
PubMed Abstract available

MYKYTYN AZ, Breugem TI, Geurts MH, Beumer J, et al
SARS-CoV-2 Omicron entry is type II transmembrane serine protease-mediated in human airway and intestinal organoid models.
J Virol. 2023 Aug 9:e0085123. doi: 10.1128/jvi.00851.
PubMed Abstract available

July 2023

SHARMA M, Chakravarty D, Hussain A, Zalavadia A, et al
Ifit2 restricts murine coronavirus spread to the spinal cord white matter and its associated myelin pathology.
J Virol. 2023 Jul 28:e0074923. doi: 10.1128/jvi.00749.
PubMed Abstract available

JENSEN JL, Sankhala RS, Dussupt V, Bai H, et al
Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity.
J Virol. 2023 Jul 3:e0159622. doi: 10.1128/jvi.01596.
PubMed Abstract available

June 2023

YANG X, Duan H, Liu X, Zhang X, et al
Broad Sarbecovirus Neutralizing Antibodies Obtained by Computational Design and Synthetic Library Screening.
J Virol. 2023 Jun 27:e0061023. doi: 10.1128/jvi.00610.
PubMed Abstract available

TERASAKI K, Narayanan K, Makino S
Identification of a 1.4-kb-Long Sequence Located in the nsp12 and nsp13 Coding Regions of SARS-CoV-2 Genomic RNA That Mediates Efficient Viral RNA Packaging.
J Virol. 2023 Jun 27:e0065923. doi: 10.1128/jvi.00659.
PubMed Abstract available

KRISTEN-BURMANN C, Rogger P, Veiga IB, Riebesehl S, et al
Reverse Genetic Assessment of the Roles Played by the Spike Protein and ORF3 in Porcine Epidemic Diarrhea Virus Pathogenicity.
J Virol. 2023 Jun 26:e0196422. doi: 10.1128/jvi.01964.
PubMed Abstract available

LI A, Zhang B, Zhao K, Yin Z, et al
SARS-CoV-2 nsp13 Restricts Episomal DNA Transcription without Affecting Chromosomal DNA.
J Virol. 2023 Jun 22:e0051223. doi: 10.1128/jvi.00512.
PubMed Abstract available

GOFFIN E, Du X, Hemmi S, Machiels B, et al
A Single Oral Immunization with a Replication-Competent Adenovirus-Vectored Vaccine Protects Mice from Influenza Respiratory Infection.
J Virol. 2023 Jun 20:e0013523. doi: 10.1128/jvi.00135.
PubMed Abstract available

ZHANG S, Zhang S, Hou Y, Huang Y, et al
Porcine Deltacoronavirus Infection Disrupts the Intestinal Mucosal Barrier and Inhibits Intestinal Stem Cell Differentiation to Goblet Cells via the Notch Signaling Pathway.
J Virol. 2023 Jun 8:e0068923. doi: 10.1128/jvi.00689.
PubMed Abstract available

May 2023

HE H, Wang W, Li L, Zhang X, et al
Activation of the NLRP1 Inflammasome and Its Role in Transmissible Gastroenteritis Coronavirus Infection.
J Virol. 2023 May 31:e0058923. doi: 10.1128/jvi.00589.
PubMed Abstract available

ZHOU C, Liu Y, Wei Q, Chen Y, et al
HSPA5 Promotes Attachment and Internalization of Porcine Epidemic Diarrhea Virus through Interaction with the Spike Protein and the Endo-/Lysosomal Pathway.
J Virol. 2023 May 24:e0054923. doi: 10.1128/jvi.00549.
PubMed Abstract available

SLANINA H, Madhugiri R, Wenk K, Reinke T, et al
Conserved Characteristics of NMPylation Activities of Alpha- and Betacoronavirus NiRAN Domains.
J Virol. 2023 May 18:e0046523. doi: 10.1128/jvi.00465.
PubMed Abstract available

JIANG H, Joshi A, Gan T, Janowski AB, et al
The Highly Conserved Stem-Loop II Motif Is Dispensable for SARS-CoV-2.
J Virol. 2023 May 18:e0063523. doi: 10.1128/jvi.00635.
PubMed Abstract available

ISHIMARU H, Nishimura M, Tjan LH, Sutandhio S, et al
Identification and Analysis of Monoclonal Antibodies with Neutralizing Activity against Diverse SARS-CoV-2 Variants.
J Virol. 2023 May 16:e0028623. doi: 10.1128/jvi.00286.
PubMed Abstract available

SENGAR A, Cervantes M, Bondalapati ST, Hess T, et al
Single-Virus Fusion Measurements Reveal Multiple Mechanistically Equivalent Pathways for SARS-CoV-2 Entry.
J Virol. 2023 May 3:e0199222. doi: 10.1128/jvi.01992.
PubMed Abstract available

LI Z, Duan P, Qiu R, Fang L, et al
HDAC6 Degrades nsp8 of Porcine Deltacoronavirus through Deacetylation and Ubiquitination to Inhibit Viral Replication.
J Virol. 2023 May 3:e0037523. doi: 10.1128/jvi.00375.
PubMed Abstract available

GUO X, Feng Y, Zhao X, Qiao S, et al
Coronavirus Porcine Epidemic Diarrhea Virus Utilizes Chemokine Interleukin-8 to Facilitate Viral Replication by Regulating Ca(2+) Flux.
J Virol. 2023 May 3:e0029223. doi: 10.1128/jvi.00292.
PubMed Abstract available

April 2023

YOU R, Liu K, Huang M, Tang L, et al
Identification and Comparison of the Sialic Acid-Binding Domain Characteristics of Avian Coronavirus Infectious Bronchitis Virus Spike Protein.
J Virol. 2023 Apr 25:e0048923. doi: 10.1128/jvi.00489.
PubMed Abstract available

SPECK P, Mackenzie J, Bull RA, Slobedman B, et al
Statement in Support of: "Virology under the Microscope-a Call for Rational Discourse".
J Virol. 2023 Apr 25:e0045123. doi: 10.1128/jvi.00451.
PubMed

KETTUNEN P, Lesnikova A, Rasanen N, Ojha R, et al
SARS-CoV-2 Infection of Human Neurons Is TMPRSS2 Independent, Requires Endosomal Cell Entry, and Can Be Blocked by Inhibitors of Host Phosphoinositol-5 Kinase.
J Virol. 2023 Apr 11:e0014423. doi: 10.1128/jvi.00144.
PubMed Abstract available

March 2023

JI Z, Dong H, Jiao R, Zhu X, et al
The TGEV Membrane Protein Interacts with HSC70 To Direct Virus Internalization through Clathrin-Mediated Endocytosis.
J Virol. 2023 Mar 28:e0012823. doi: 10.1128/jvi.00128.
PubMed Abstract available

CHEN XN, Liang YF, Weng ZJ, Quan WP, et al
Porcine Enteric Alphacoronavirus Entry through Multiple Pathways (Caveolae, Clathrin, and Macropinocytosis) Requires Rab GTPases for Endosomal Transport.
J Virol. 2023 Mar 28:e0021023. doi: 10.1128/jvi.00210.
PubMed Abstract available

ALWINE JC, Casadevall A, Enquist LW, Goodrum FD, et al
A critical analysis of the evidence for the SARS-CoV-2 origin hypotheses.
J Virol. 2023 Mar 10:e0036523. doi: 10.1128/jvi.00365.
PubMed Abstract available

WANG X, Wang W, Wang T, Wang J, et al
SARS-CoV-2 ORF8 Protein Induces Endoplasmic Reticulum Stress-like Responses and Facilitates Virus Replication by Triggering Calnexin: an Unbiased Study.
J Virol. 2023 Mar 6:e0001123. doi: 10.1128/jvi.00011.
PubMed Abstract available

DUAN Y, Yuan C, Suo X, Li Y, et al
Bat-Origin Swine Acute Diarrhea Syndrome Coronavirus Is Lethal to Neonatal Mice.
J Virol. 2023 Mar 6:e0019023. doi: 10.1128/jvi.00190.
PubMed Abstract available

MOLS VC, Lamers MM, Leijten LM, Breugem TI, et al
Intestinal Tropism of a Betacoronavirus (Merbecovirus) in Nathusius's Pipistrelle Bat (Pipistrellus nathusii), Its Natural Host.
J Virol. 2023 Mar 1:e0009923. doi: 10.1128/jvi.00099.
PubMed Abstract available

February 2023

FROLOV I, Agback T, Palchevska O, Dominguez F, et al
All Domains of SARS-CoV-2 nsp1 Determine Translational Shutoff and Cytotoxicity of the Protein.
J Virol. 2023 Feb 27:e0186522. doi: 10.1128/jvi.01865.
PubMed Abstract available

QIN W, Qi X, Xie Y, Wang H, et al
LncRNA446 Regulates Tight Junctions by Inhibiting the Ubiquitinated Degradation of Alix after Porcine Epidemic Diarrhea Virus Infection.
J Virol. 2023 Feb 15:e0188422. doi: 10.1128/jvi.01884.
PubMed Abstract available

ZHANG L, Hom N, Ojha A, Lovendahl KN, et al
Cytoplasmic Tail Truncation Stabilizes S1-S2 Association and Enhances S Protein Incorporation into SARS-CoV-2 Pseudovirions.
J Virol. 2023 Feb 15:e0165022. doi: 10.1128/jvi.01650.
PubMed Abstract available

WANG X, Wen Z, Cao H, Luo J, et al
Transferrin Receptor Protein 1 Cooperates with mGluR2 To Mediate the Internalization of Rabies Virus and SARS-CoV-2.
J Virol. 2023 Feb 13:e0161122. doi: 10.1128/jvi.01611.
PubMed Abstract available

KEEP S, Dowgier G, Lulla V, Britton P, et al
Deletion of the s2m RNA Structure in the Avian Coronavirus Infectious Bronchitis Virus and Human Astrovirus Results in Sequence Insertions.
J Virol. 2023 Feb 13:e0003823. doi: 10.1128/jvi.00038.
PubMed Abstract available

AMANAT F, Clark J, Carreno JM, Strohmeier S, et al
Immunity to Seasonal Coronavirus Spike Proteins Does Not Protect from SARS-CoV-2 Challenge in a Mouse Model but Has No Detrimental Effect on Protection Mediated by COVID-19 mRNA Vaccination.
J Virol. 2023 Feb 13:e0166422. doi: 10.1128/jvi.01664.
PubMed Abstract available

ZHOU H, Yan Y, Gao J, Ma M, et al
Heterogeneous Nuclear Protein U Degraded the m(6)A Methylated TRAF3 Transcript by YTHDF2 To Promote Porcine Epidemic Diarrhea Virus Replication.
J Virol. 2023 Feb 8:e0175122. doi: 10.1128/jvi.01751.
PubMed Abstract available

LIN J, Law R, Korosec CS, Zhou C, et al
Erratum for Lin et al., "Longitudinal Assessment of SARS-CoV-2-Specific T Cell Cytokine-Producing Responses for 1 Year Reveals Persistence of Multicytokine Proliferative Responses, with Greater Immunity Associated with Disease Severity".
J Virol. 2023 Feb 7:e0008023. doi: 10.1128/jvi.00080.
PubMed

BEI C, Zhang C, Wu H, Feng H, et al
DDX3X Is Hijacked by Snakehead Vesiculovirus Phosphoprotein To Facilitate Virus Replication via Stabilization of the Phosphoprotein.
J Virol. 2023 Feb 6:e0003523. doi: 10.1128/jvi.00035.
PubMed Abstract available

SCHINDEWOLF C, Lokugamage K, Vu MN, Johnson BA, et al
SARS-CoV-2 Uses Nonstructural Protein 16 To Evade Restriction by IFIT1 and IFIT3.
J Virol. 2023 Feb 1:e0153222. doi: 10.1128/jvi.01532.
PubMed Abstract available

January 2023

ZHAI X, Kong N, Wang C, Qin W, et al
PRPF19 Limits Porcine Epidemic Diarrhea Virus Replication through Targeting and Degrading Viral Capsid Protein.
J Virol. 2023;97:e0161422.
PubMed Abstract available

GOODRUM F, Lowen A, Lakdawala S, Alwine J, et al
Virology under the Microscope-a Call for Rational Discourse.
J Virol. 2023 Jan 26:e0008923. doi: 10.1128/jvi.00089.
PubMed Abstract available

LIU MQ, Lin HF, Li J, Chen Y, et al
A SARS-CoV-2-Related Virus from Malayan Pangolin Causes Lung Infection without Severe Disease in Human ACE2-Transgenic Mice.
J Virol. 2023 Jan 23:e0171922. doi: 10.1128/jvi.01719.
PubMed Abstract available

RAJAGOPALA SV, Strickland BA, Pakala SB, Kimura KS, et al
Mucosal Gene Expression in Response to SARS-CoV-2 Is Associated with Viral Load.
J Virol. 2023 Jan 19:e0147822. doi: 10.1128/jvi.01478.
PubMed Abstract available

LIANG QZ, Wang B, Ji CM, Hu F, et al
Chicken or Porcine Aminopeptidase N Mediates Cellular Entry of Pseudoviruses Carrying Spike Glycoprotein from the Avian Deltacoronaviruses HKU11, HKU13, and HKU17.
J Virol. 2023 Jan 19:e0194722. doi: 10.1128/jvi.01947.
PubMed Abstract available

MA J, Liu X, Zhou M, Chen P, et al
A Heterologous Challenge Rescues the Attenuated Immunogenicity of SARS-CoV-2 Omicron BA.1 Variant in Syrian Hamster Model.
J Virol. 2023 Jan 18:e0168422. doi: 10.1128/jvi.01684.
PubMed Abstract available

SHIWA-SUDO N, Sakai Y, Iwata-Yoshikawa N, Watanabe S, et al
Impact of Reinfection with SARS-CoV-2 Omicron Variants in Previously Infected Hamsters.
J Virol. 2023 Jan 12:e0136622. doi: 10.1128/jvi.01366.
PubMed Abstract available

December 2022

CHANG P, Lukosaityte D, Sealy JE, Rijal P, et al
Antigenic Characterization of Human Monoclonal Antibodies for Therapeutic Use against H7N9 Avian Influenza Virus.
J Virol. 2022 Dec 21:e0143122. doi: 10.1128/jvi.01431.
PubMed Abstract available

CHEN Y, Wu Y, Chen S, Zhan Q, et al
Sertraline Is an Effective SARS-CoV-2 Entry Inhibitor Targeting the Spike Protein.
J Virol. 2022 Dec 5:e0124522. doi: 10.1128/jvi.01245.
PubMed Abstract available

WANG X, Jin Q, Xiao W, Fang P, et al
Genome-Wide CRISPR/Cas9 Screen Reveals a Role for SLC35A1 in the Adsorption of Porcine Deltacoronavirus.
J Virol. 2022 Dec 1:e0162622. doi: 10.1128/jvi.01626.
PubMed Abstract available

November 2022

CHOI SSA, Chan HH, Chan CM, Wang X, et al
Neuromasts and Olfactory Organs of Zebrafish Larvae Represent Possible Sites of SARS-CoV-2 Pseudovirus Host Cell Entry.
J Virol. 2022 Nov 30:e0141822. doi: 10.1128/jvi.01418.
PubMed Abstract available

BELSER JA, Sun X, Kieran TJ, Brock N, et al
Detection of Airborne Influenza A and SARS-CoV-2 Virus Shedding following Ocular Inoculation of Ferrets.
J Virol. 2022 Nov 30:e0140322. doi: 10.1128/jvi.01403.
PubMed Abstract available

XUE M, Wang W, He H, Li L, et al
Different Mechanisms Are Utilized by Coronavirus Transmissible Gastroenteritis Virus To Regulate Interferon Lambda 1 and Interferon Lambda 3 Production.
J Virol. 2022 Nov 30:e0138822. doi: 10.1128/jvi.01388.
PubMed Abstract available

NIU Z, Xu S, Zhang Y, Kan Z, et al
Transmissible Gastroenteritis Virus Nucleocapsid Protein Interacts with Na(+)/H(+) Exchanger 3 To Reduce Na(+)/H(+) Exchanger Activity and Promote Piglet Diarrhea.
J Virol. 2022;96:e0147322.
PubMed Abstract available

TAN TS, Toyoda M, Ode H, Barabona G, et al
Erratum for Tan et al., "Dissecting Naturally Arising Amino Acid Substitutions at Position L452 of SARS-CoV-2 Spike".
J Virol. 2022 Nov 21:e0173722. doi: 10.1128/jvi.01737.
PubMed

LISTA MJ, Winstone H, Wilson HD, Dyer A, et al
The P681H Mutation in the Spike Glycoprotein of the Alpha Variant of SARS-CoV-2 Escapes IFITM Restriction and Is Necessary for Type I Interferon Resistance.
J Virol. 2022 Nov 9:e0125022. doi: 10.1128/jvi.01250.
PubMed Abstract available

WANG X, Kerkmann L, Hetzel M, Windmann S, et al
Analysis of the Prevalence of Binding and Neutralizing Antibodies against 39 Human Adenovirus Types in Student Cohorts Reveals Low-Prevalence Types and a Decline in Binding Antibody Levels during the SARS-CoV-2 Pandemic.
J Virol. 2022 Nov 7:e0113322. doi: 10.1128/jvi.01133.
PubMed Abstract available

CZERKIES M, Kochanczyk M, Korwek Z, Prus W, et al
Respiratory Syncytial Virus Protects Bystander Cells against Influenza A Virus Infection by Triggering Secretion of Type I and Type III Interferons.
J Virol. 2022 Nov 3:e0134122. doi: 10.1128/jvi.01341.
PubMed Abstract available

QIN W, Kong N, Wang C, Dong S, et al
hnRNP K Degrades Viral Nucleocapsid Protein and Induces Type I IFN Production to Inhibit Porcine Epidemic Diarrhea Virus Replication.
J Virol. 2022 Nov 1:e0155522. doi: 10.1128/jvi.01555.
PubMed Abstract available

October 2022

LAU SKP, Poon RWS, Wong BHL, Wang M, et al
Retraction for Lau et al., "Coexistence of Different Genotypes in the Same Bat and Serological Characterization of Rousettus Bat Coronavirus HKU9 Belonging to a Novel Betacoronavirus Subgroup".
J Virol. 2022 Oct 31:e0148522. doi: 10.1128/jvi.01485.
PubMed

WOO PCY, Lau SKP, Lam CSF, Tsang AKL, et al
Retraction for Woo et al., "Discovery of a Novel Bottlenose Dolphin Coronavirus Reveals a Distinct Species of Marine Mammal Coronavirus in Gammacoronavirus".
J Virol. 2022 Oct 31:e0150322. doi: 10.1128/jvi.01503.
PubMed

SIU KL, Yeung ML, Kok KH, Yuen KS, et al
Retraction for Siu et al., "Middle East Respiratory Syndrome Coronavirus 4a Protein Is a Double-Stranded RNA-Binding Protein That Suppresses PACT-Induced Activation of RIG-I and MDA5 in the Innate Antiviral Response".
J Virol. 2022 Oct 31:e0150422. doi: 10.1128/jvi.01504.
PubMed

SACCO MT, Bland KM, Horner SM
WTAP Targets the METTL3 m(6)A-Methyltransferase Complex to Cytoplasmic Hepatitis C Virus RNA to Regulate Infection.
J Virol. 2022 Oct 31:e0099722. doi: 10.1128/jvi.00997.
PubMed Abstract available

TAN TS, Toyoda M, Ode H, Barabona G, et al
Dissecting Naturally Arising Amino Acid Substitutions at Position L452 of SARS-CoV-2 Spike.
J Virol. 2022 Oct 10:e0116222. doi: 10.1128/jvi.01162.
PubMed Abstract available

September 2022

CHEN M, Wang MH, Shen XG, Liu H, et al
Neuropilin-1 Facilitates Pseudorabies Virus Replication and Viral Glycoprotein B Promotes Its Degradation in a Furin-Dependent Manner.
J Virol. 2022 Sep 29:e0131822. doi: 10.1128/jvi.01318.
PubMed Abstract available

YANG N, Zhang Y, Fu Y, Li Y, et al
Transmissible Gastroenteritis Virus Infection Promotes the Self-Renewal of Porcine Intestinal Stem Cells via Wnt/beta-Catenin Pathway.
J Virol. 2022;96:e0096222.
PubMed Abstract available

GELLENONCOURT S, Saunders N, Robinot R, Auguste L, et al
The Spike-Stabilizing D614G Mutation Interacts with S1/S2 Cleavage Site Mutations To Promote the Infectious Potential of SARS-CoV-2 Variants.
J Virol. 2022 Sep 19:e0130122. doi: 10.1128/jvi.01301.
PubMed Abstract available

AO Z, Ouyang MJ, Olukitibi TA, Warner B, et al
A Recombinant VSV-Based Bivalent Vaccine Effectively Protects against Both SARS-CoV-2 and Influenza A Virus Infection.
J Virol. 2022 Sep 7:e0133722. doi: 10.1128/jvi.01337.
PubMed Abstract available

August 2022

ZHANG C, Cui H, Guo Z, Chen Z, et al
SARS-CoV-2 Virus Culture, Genomic and Subgenomic RNA Load, and Rapid Antigen Test in Experimentally Infected Syrian Hamsters.
J Virol. 2022 Aug 30:e0103422. doi: 10.1128/jvi.01034.
PubMed Abstract available

FAN B, Peng Q, Song S, Shi D, et al
Nonstructural Protein 1 of Variant PEDV Plays a Key Role in Escaping Replication Restriction by Complement C3.
J Virol. 2022 Aug 29:e0102422. doi: 10.1128/jvi.01024.
PubMed Abstract available

MARTINS M, do Nascimento GM, Nooruzzaman M, Yuan F, et al
The Omicron Variant BA.1.1 Presents a Lower Pathogenicity than B.1 D614G and Delta Variants in a Feline Model of SARS-CoV-2 Infection.
J Virol. 2022 Aug 24:e0096122. doi: 10.1128/jvi.00961.
PubMed Abstract available

SU C, He J, Han P, Bai B, et al
Molecular Basis of Mink ACE2 Binding to SARS-CoV-2 and Its Mink-Derived Variants.
J Virol. 2022 Aug 24:e0081422. doi: 10.1128/jvi.00814.
PubMed Abstract available

KAZEMI S, Lopez-Munoz AD, Holly J, Jin L, et al
Variations in Cell Surface ACE2 Levels Alter Direct Binding of SARS-CoV-2 Spike Protein and Viral Infectivity: Implications for Measuring Spike Protein Interactions with Animal ACE2 Orthologs.
J Virol. 2022 Aug 24:e0025622. doi: 10.1128/jvi.00256.
PubMed Abstract available

JIAO Z, Yan Y, Chen Y, Wang G, et al
Adaptive Mutation in the Main Protease Cleavage Site of Feline Coronavirus Renders the Virus More Resistant to Main Protease Inhibitors.
J Virol. 2022 Aug 24:e0090722. doi: 10.1128/jvi.00907.
PubMed Abstract available

NEERUKONDA SN, Wang R, Vassell R, Baha H, et al
Characterization of Entry Pathways, Species-Specific Angiotensin-Converting Enzyme 2 Residues Determining Entry, and Antibody Neutralization Evasion of Omicron BA.1, BA.1.1, BA.2, and BA.3 Variants.
J Virol. 2022 Aug 24:e0114022. doi: 10.1128/jvi.01140.
PubMed Abstract available

CHEN Y, Jiang RD, Wang Q, Luo Y, et al
Lethal Swine Acute Diarrhea Syndrome Coronavirus Infection in Suckling Mice.
J Virol. 2022 Aug 22:e0006522. doi: 10.1128/jvi.00065.
PubMed Abstract available

ZHOU Y, Zheng R, Liu D, Liu S, et al
UBR5 Acts as an Antiviral Host Factor against MERS-CoV via Promoting Ubiquitination and Degradation of ORF4b.
J Virol. 2022 Aug 18:e0074122. doi: 10.1128/jvi.00741.
PubMed Abstract available

GUPTA SL, Mantus G, Manning KE, Ellis M, et al
Loss of Pfizer (BNT162b2) Vaccine-Induced Antibody Responses against the SARS-CoV-2 Omicron Variant in Adolescents and Adults.
J Virol. 2022 Aug 17:e0058222. doi: 10.1128/jvi.00582.
PubMed Abstract available

KEEP S, Stevenson-Leggett P, Dowgier G, Foldes K, et al
A Temperature-Sensitive Recombinant of Avian Coronavirus Infectious Bronchitis Virus Provides Complete Protection against Homologous Challenge.
J Virol. 2022 Aug 16:e0110022. doi: 10.1128/jvi.01100.
PubMed Abstract available

YUAN C, Suo X, Duan Y, Li X, et al
Comprehensive Subcellular Localization of Swine Acute Diarrhea Syndrome Coronavirus Proteins.
J Virol. 2022 Aug 16:e0077222. doi: 10.1128/jvi.00772.
PubMed Abstract available

HAN Y, Bai X, Liu S, Zhu J, et al
XAF1 Protects Host against Emerging RNA Viruses by Stabilizing IRF1-Dependent Antiviral Immunity.
J Virol. 2022 Aug 16:e0077422. doi: 10.1128/jvi.00774.
PubMed Abstract available

SHI J, Zheng J, Tai W, Verma AK, et al
A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.
J Virol. 2022 Aug 16:e0011822. doi: 10.1128/jvi.00118.
PubMed Abstract available

UNDI RB, Larabee JL, Filiberti A, Ulahannan S, et al
Targeting Doublecortin-Like Kinase 1 (DCLK1)-Regulated SARS-CoV-2 Pathogenesis in COVID-19.
J Virol. 2022 Aug 9:e0096722. doi: 10.1128/jvi.00967.
PubMed Abstract available

VETTER J, Papa G, Seyffert M, Gunasekera K, et al
Rotavirus Spike Protein VP4 Mediates Viroplasm Assembly by Association to Actin Filaments.
J Virol. 2022 Aug 8:e0107422. doi: 10.1128/jvi.01074.
PubMed Abstract available

ANDERSON-DANIELS J, Gribble J, Denison M
Proteolytic Processing of the Coronavirus Replicase Nonstructural Protein 14 Exonuclease Is Not Required for Virus Replication but Alters RNA Synthesis and Viral Fitness.
J Virol. 2022 Aug 4:e0084122. doi: 10.1128/jvi.00841.
PubMed Abstract available

ABDELNABI R, Foo CS, Kaptein SJF, Boudewijns R, et al
A SCID Mouse Model To Evaluate the Efficacy of Antivirals against SARS-CoV-2 Infection.
J Virol. 2022 Aug 4:e0075822. doi: 10.1128/jvi.00758.
PubMed Abstract available

CAMPAGNOLA G, Govindarajan V, Pelletier A, Canard B, et al
The SARS-CoV nsp12 Polymerase Active Site Is Tuned for Large-Genome Replication.
J Virol. 2022 Aug 4:e0067122. doi: 10.1128/jvi.00671.
PubMed Abstract available

ZHAN W, Tian X, Zhang X, Xing S, et al
Structural Study of SARS-CoV-2 Antibodies Identifies a Broad-Spectrum Antibody That Neutralizes the Omicron Variant by Disassembling the Spike Trimer.
J Virol. 2022 Aug 4:e0048022. doi: 10.1128/jvi.00480.
PubMed Abstract available

LI Z, Fang P, Duan P, Chen J, et al
Porcine Deltacoronavirus Infection Cleaves HDAC2 to Attenuate Its Antiviral Activity.
J Virol. 2022 Aug 2:e0102722. doi: 10.1128/jvi.01027.
PubMed Abstract available

YUAN M, Chen X, Zhu Y, Dong X, et al
A Bispecific Antibody Targeting RBD and S2 Potently Neutralizes SARS-CoV-2 Omicron and Other Variants of Concern.
J Virol. 2022 Aug 2:e0077522. doi: 10.1128/jvi.00775.
PubMed Abstract available

July 2022

FROLOVA EI, Palchevska O, Lukash T, Dominguez F, et al
Acquisition of Furin Cleavage Site and Further SARS-CoV-2 Evolution Change the Mechanisms of Viral Entry, Infection Spread, and Cell Signaling.
J Virol. 2022 Jul 25:e0075322. doi: 10.1128/jvi.00753.
PubMed Abstract available

AKAISHI T, Horii A, Ishii T
Sequence Exchange Involving Dozens of Consecutive Bases with External Origin in SARS-Related Coronaviruses.
J Virol. 2022 Jul 20:e0100222. doi: 10.1128/jvi.01002.
PubMed

GUO H, Li A, Lin HF, Liu MQ, et al
The Glycan-Binding Trait of the Sarbecovirus Spike N-Terminal Domain Reveals an Evolutionary Footprint.
J Virol. 2022 Jul 19:e0095822. doi: 10.1128/jvi.00958.
PubMed Abstract available

MOYO-GWETE T, Madzivhandila M, Mkhize NN, Kgagudi P, et al
Shared N417-Dependent Epitope on the SARS-CoV-2 Omicron, Beta, and Delta Plus Variants.
J Virol. 2022 Jul 13:e0055822. doi: 10.1128/jvi.00558.
PubMed Abstract available

DONG S, Kong N, Wang C, Li Y, et al
FUBP3 Degrades the Porcine Epidemic Diarrhea Virus Nucleocapsid Protein and Induces the Production of Type I Interferon.
J Virol. 2022;96:e0061822.
PubMed Abstract available

PUSNIK J, Konig J, Mai K, Richter E, et al
Persistent Maintenance of Intermediate Memory B Cells Following SARS-CoV-2 Infection and Vaccination Recall Response.
J Virol. 2022 Jul 12:e0076022. doi: 10.1128/jvi.00760.
PubMed Abstract available

CHAPARIAN RR, Harding AT, Hamele CE, Riebe K, et al
A Virion-Based Combination Vaccine Protects against Influenza and SARS-CoV-2 Disease in Mice.
J Virol. 2022 Jul 12:e0068922. doi: 10.1128/jvi.00689.
PubMed Abstract available

OISHI K, Horiuchi S, Minkoff JM, tenOever BR, et al
The Host Response to Influenza A Virus Interferes with SARS-CoV-2 Replication during Coinfection.
J Virol. 2022 Jul 12:e0076522. doi: 10.1128/jvi.00765.
PubMed Abstract available

AICHER SM, Streicher F, Chazal M, Planas D, et al
Species-Specific Molecular Barriers to SARS-CoV-2 Replication in Bat Cells.
J Virol. 2022 Jul 5:e0060822. doi: 10.1128/jvi.00608.
PubMed Abstract available

XING N, Wang Z, Wang J, Nascimento M, et al
Engineering and Characterization of Avian Coronavirus Mutants Expressing Fluorescent Reporter Proteins from the Replicase Gene.
J Virol. 2022 Jul 5:e0065322. doi: 10.1128/jvi.00653.
PubMed Abstract available

June 2022

VAN OOSTEN L, Yan K, Rawle DJ, Le TT, et al
An S1-Nanoparticle Vaccine Protects against SARS-CoV-2 Challenge in K18-hACE2 Mice.
J Virol. 2022 Jun 29:e0084422. doi: 10.1128/jvi.00844.
PubMed

JIANG C, Li L, Xue M, Zhao L, et al
Long-Term Expanding Porcine Airway Organoids Provide Insights into the Pathogenesis and Innate Immunity of Porcine Respiratory Coronavirus Infection.
J Virol. 2022 Jun 28:e0073822. doi: 10.1128/jvi.00738.
PubMed Abstract available

DIEBOLD O, Gonzalez V, Venditti L, Sharp C, et al
Using Species a Rotavirus Reverse Genetics to Engineer Chimeric Viruses Expressing SARS-CoV-2 Spike Epitopes.
J Virol. 2022 Jun 27:e0048822. doi: 10.1128/jvi.00488.
PubMed Abstract available

YUAN C, Zhang P, Liu P, Li Y, et al
A Novel Pathway for Porcine Epidemic Diarrhea Virus Transmission from Sows to Neonatal Piglets Mediated by Colostrum.
J Virol. 2022 Jun 27:e0047722. doi: 10.1128/jvi.00477.
PubMed Abstract available

BI W, Chen G, Dang B
Novel Engineered SARS-CoV-2 HR1 Trimer Exhibits Improved Potency and Broad-Spectrum Activity against SARS-CoV-2 and Its Variants.
J Virol. 2022 Jun 23:e0068122. doi: 10.1128/jvi.00681.
PubMed Abstract available

CHAN CE, Ng CG, Lim AP, Seah SL, et al
The Cellular Characterization of SARS-CoV-2 Spike Protein in Virus-Infected Cells Using the Receptor Binding Domain Binding Specific Human Monoclonal Antibodies.
J Virol. 2022 Jun 21:e0045522. doi: 10.1128/jvi.00455.
PubMed Abstract available

LIN J, Law R, Korosec CS, Zhou C, et al
Longitudinal Assessment of SARS-CoV-2-Specific T Cell Cytokine-Producing Responses for 1 Year Reveals Persistence of Multicytokine Proliferative Responses, with Greater Immunity Associated with Disease Severity.
J Virol. 2022 Jun 14:e0050922. doi: 10.1128/jvi.00509.
PubMed Abstract available

SUN C, Yuan RY, Xie C, Sun JF, et al
Induction of Broadly Cross-Reactive Antibody Responses to SARS-CoV-2 Variants by S1 Nanoparticle Vaccines.
J Virol. 2022 Jun 14:e0038322. doi: 10.1128/jvi.00383.
PubMed Abstract available

LAVIE M, Dubuisson J, Belouzard S
SARS-CoV-2 Spike Furin Cleavage Site and S2' Basic Residues Modulate the Entry Process in a Host Cell-Dependent Manner.
J Virol. 2022 Jun 9:e0047422. doi: 10.1128/jvi.00474.
PubMed Abstract available

SEVENICH M, van den Heuvel J, Gering I, Mohrluder J, et al
A So-Far Overlooked Secondary Conformation State in the Binding Mode of SARS-CoV-2 Spike Protein to Human ACE2 and Its Conversion Rate Are Crucial for Estimating Infectivity Efficacy of the Underlying Virus Variant.
J Virol. 2022 Jun 8:e0068522. doi: 10.1128/jvi.00685.
PubMed Abstract available

ESSALMANI R, Jain J, Susan-Resiga D, Andreo U, et al
Erratum for Essalmani et al., "Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity".
J Virol. 2022 Jun 6:e0074522. doi: 10.1128/jvi.00745.
PubMed

CHEN X, Li J, Yang L, Zhou Y, et al
Immunoglobin G Sero-Dynamics Aided Host Specific Linear Epitope Identification and Differentiation of Infected from Vaccinated Hosts.
J Virol. 2022 Jun 6:e0014322. doi: 10.1128/jvi.00143.
PubMed Abstract available

LIU H, Bai Y, Zhang X, Gao T, et al
SARS-CoV-2 N Protein Antagonizes Stress Granule Assembly and IFN Production by Interacting with G3BPs to Facilitate Viral Replication.
J Virol. 2022 Jun 2:e0041222. doi: 10.1128/jvi.00412.
PubMed Abstract available

May 2022

ZHAO J, Feng D, Zhao Y, Huang M, et al
Role of Stress Granules in Suppressing Viral Replication by the Infectious Bronchitis Virus Endoribonuclease.
J Virol. 2022 May 31:e0068622. doi: 10.1128/jvi.00686.
PubMed Abstract available

DIJKMAN R, Verma AK, Selvaraj M, Ghimire R, et al
Effective Interferon Lambda Treatment Regimen To Control Lethal MERS-CoV Infection in Mice.
J Virol. 2022 May 19:e0036422. doi: 10.1128/jvi.00364.
PubMed Abstract available

NIU X, Kong F, Xu J, Liu M, et al
Mutations in Porcine Epidemic Diarrhea Virus nsp1 Cause Increased Viral Sensitivity to Host Interferon Responses and Attenuation In Vivo.
J Virol. 2022 May 18:e0046922. doi: 10.1128/jvi.00469.
PubMed Abstract available

NCHIOUA R, Schundner A, Kmiec D, Prelli Bozzo C, et al
SARS-CoV-2 Variants of Concern Hijack IFITM2 for Efficient Replication in Human Lung Cells.
J Virol. 2022 May 11:e0059422. doi: 10.1128/jvi.00594.
PubMed Abstract available

DONG S, Kong N, Zhang Y, Li Y, et al
TARDBP Inhibits Porcine Epidemic Diarrhea Virus Replication through Degrading Viral Nucleocapsid Protein and Activating Type I Interferon Signaling.
J Virol. 2022 May 2:e0007022. doi: 10.1128/jvi.00070.
PubMed Abstract available

April 2022

ZHANG J, Yuan S, Peng Q, Ding Z, et al
Porcine Epidemic Diarrhea Virus nsp7 Inhibits Interferon-Induced JAK-STAT Signaling through Sequestering the Interaction between KPNA1 and STAT1.
J Virol. 2022 Apr 20:e0040022. doi: 10.1128/jvi.00400.
PubMed Abstract available

LI J, Li Y, Liu P, Wang X, et al
Porcine Epidemic Diarrhea Virus Infection Disrupts the Nasal Endothelial Barrier To Favor Viral Dissemination.
J Virol. 2022 Apr 18:e0038022. doi: 10.1128/jvi.00380.
PubMed Abstract available

ZHENG XS, Wang Q, Min J, Shen XR, et al
Single-Cell Landscape of Lungs Reveals Key Role of Neutrophil-Mediated Immunopathology during Lethal SARS-CoV-2 Infection.
J Virol. 2022 Apr 14:e0003822. doi: 10.1128/jvi.00038.
PubMed Abstract available

AGUILAR EG, Paniccia G, Adura C, Singer ZS, et al
Sindbis Macrodomain Poly-ADP-Ribose Hydrolase Activity Is Important for Viral RNA Synthesis.
J Virol. 2022;96:e0151621.
PubMed Abstract available

DESCHAMBAULT Y, Lynch J, Warner B, Tierney K, et al
Single Immunization with Recombinant ACAM2000 Vaccinia Viruses Expressing the Spike and the Nucleocapsid Proteins Protects Hamsters against SARS-CoV-2-Caused Clinical Disease.
J Virol. 2022 Apr 12:e0038922. doi: 10.1128/jvi.00389.
PubMed Abstract available

LANGLEY WA, Wieland A, Ahmed H, Rasheed MAU, et al
Persistence of Virus-Specific Antibody after Depletion of Memory B Cells.
J Virol. 2022 Apr 11:e0002622. doi: 10.1128/jvi.00026.
PubMed Abstract available

CHEN J, Li Z, Guo J, Xu S, et al
SARS-CoV-2 nsp5 Exhibits Stronger Catalytic Activity and Interferon Antagonism than Its SARS-CoV Ortholog.
J Virol. 2022 Apr 7:e0003722. doi: 10.1128/jvi.00037.
PubMed Abstract available

FARIAS JP, da Silva PS, Fogaca MMC, Santana IVR, et al
The COVID-19 Humoral Immunological Status Induced by CoronaVac and AstraZeneca Vaccines Significantly Benefits from a Booster Shot with the Pfizer Vaccine.
J Virol. 2022 Apr 7:e0017722. doi: 10.1128/jvi.00177.
PubMed Abstract available

LI J, Lin C, Zhou X, Zhong F, et al
Structural Basis of the Main Proteases of Coronavirus Bound to Drug Candidate PF-07321332.
J Virol. 2022 Apr 7:e0201321. doi: 10.1128/jvi.02013.
PubMed Abstract available

KLASSE PJ, Moore JP
Reappraising the Value of HIV-1 Vaccine Correlates of Protection Analyses.
J Virol. 2022 Apr 6:e0003422. doi: 10.1128/jvi.00034.
PubMed Abstract available

March 2022

HANCOCK TJ, Hickman P, Kazerooni N, Kennedy M, et al
Possible Cross-Reactivity of Feline and White-Tailed Deer Antibodies against the SARS-CoV-2 Receptor Binding Domain.
J Virol. 2022 Mar 30:e0025022. doi: 10.1128/jvi.00250.
PubMed Abstract available

ESSALMANI R, Jain J, Susan-Resiga D, Andreo U, et al
Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
J Virol. 2022 Mar 28:e0012822. doi: 10.1128/jvi.00128.
PubMed Abstract available

GENG Q, Shi K, Ye G, Zhang W, et al
Structural Basis for Human Receptor Recognition by SARS-CoV Omicron Variant BA.1.
J Virol. 2022 Mar 28:e0024922. doi: 10.1128/jvi.00249.
PubMed Abstract available

LIU MQ, Jiang RD, Guo J, Chen Y, et al
Inactivated SARS-CoV-2 Vaccine Shows Cross-Protection against Bat SARS-Related Coronaviruses in Human ACE2 Transgenic Mice.
J Virol. 2022 Mar 28:e0016922. doi: 10.1128/jvi.00169.
PubMed Abstract available

XIANG J, Lu M, Shi M, Cheng X, et al
Heparanase Blockade as a Novel Dual-Targeting Therapy for COVID-19.
J Virol. 2022 Mar 23:e0005722. doi: 10.1128/jvi.00057.
PubMed Abstract available

LIU X, Yin L, Xue M, Chen J, et al
Coronavirus Porcine Deltacoronavirus Upregulates MHC Class I Expression through RIG-I/IRF1-Mediated NLRC5 Induction.
J Virol. 2022 Mar 21:e0015822. doi: 10.1128/jvi.00158.
PubMed Abstract available

REINECKE B, Frericks N, Lauber C, Dinkelborg K, et al
The Human Liver-Expressed Lectin CD302 Restricts Hepatitis C Virus Infection.
J Virol. 2022 Mar 17:e0199521. doi: 10.1128/jvi.01995.
PubMed Abstract available

BERKHOUT B, Herrera-Carrillo E
SARS-CoV-2 Evolution: On the Sudden Appearance of the Omicron Variant.
J Virol. 2022 Mar 16:e0009022. doi: 10.1128/jvi.00090.
PubMed Abstract available

GAO J, Tang YD, Hu W, Zheng C, et al
When Poly(A) Binding Proteins Meet Viral Infections, Including SARS-CoV-2.
J Virol. 2022 Mar 16:e0013622. doi: 10.1128/jvi.00136.
PubMed Abstract available

METZ-ZUMARAN C, Kee C, Doldan P, Guo C, et al
Increased Sensitivity of SARS-CoV-2 to Type III Interferon in Human Intestinal Epithelial Cells.
J Virol. 2022 Mar 9:e0170521. doi: 10.1128/jvi.01705.
PubMed Abstract available

LI M, Wu Y, Chen J, Shi H, et al
Innate Immune Evasion of Porcine Epidemic Diarrhea Virus through Degradation of the FBXW7 Protein via the Ubiquitin-Proteasome Pathway.
J Virol. 2022;96:e0088921.
PubMed Abstract available

February 2022

JUNG C, Kmiec D, Koepke L, Zech F, et al
Omicron: what makes the latest SARS-CoV-2 variant of concern so concerning?
J Virol. 2022 Feb 28:jvi0207721. doi: 10.1128/jvi.02077.
PubMed Abstract available

KIM EH, Nguyen TQ, Casel MAB, Rollon R, et al
Coinfection of SARS-CoV-2 and Influenza A virus increased disease severity, impaired neutralizing antibody, and CD4+ T cell responses.
J Virol. 2022 Feb 2:jvi0187321. doi: 10.1128/jvi.01873.
PubMed Abstract available

ARIUMI Y
Host cellular RNA helicases regulate SARS-CoV-2 infection.
J Virol. 2022 Feb 2:jvi0000222. doi: 10.1128/jvi.00002.
PubMed Abstract available

January 2022

LIU S, Chou CK, Wu WW, Luan B, et al
Stable Cell Clones Harboring Self-Replicating SARS-CoV-2 RNAs for Drug Screen.
J Virol. 2022 Jan 26:jvi0221621. doi: 10.1128/jvi.02216.
PubMed Abstract available

WONG TY, Horspool AM, Russ BP, Ye C, et al
Evaluating antibody mediated protection against Alpha, Beta, and Delta SARS-CoV-2 variants of concern in K18-hACE2 transgenic mice.
J Virol. 2022 Jan 26:jvi0218421. doi: 10.1128/jvi.02184.
PubMed Abstract available

CHEN W, Huang C, Shi Y, Li N, et al
Investigation of the Crosstalk between GRP78/PERK/ATF-4 Signaling Pathway and Renal Apoptosis Induced by Nephropathogenic Infectious Bronchitis Virus Infection.
J Virol. 2022;96:e0142921.
PubMed Abstract available

DU S, Xu W, Wang Y, Li L, et al
The "LLQY" motif on SARS-CoV-2 spike protein affects S incorporation into virus particles.
J Virol. 2022 Jan 19:jvi0189721. doi: 10.1128/jvi.01897.
PubMed Abstract available

KEEP S, Stevenson-Leggett P, Dowgier G, Everest H, et al
Identification of amino acids within non-structural proteins 10 and 14 of the avian coronavirus infectious bronchitis virus that result in attenuation in vivo and in ovo.
J Virol. 2022 Jan 19:jvi0205921. doi: 10.1128/jvi.02059.
PubMed Abstract available

CHAUDHRY MZ, Eschke K, Hoffmann M, Grashoff M, et al
Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases.
J Virol. 2022 Jan 12:jvi0218621. doi: 10.1128/jvi.02186.
PubMed Abstract available

Articles of Significant Interest in This Issue.
J Virol. 2022;96:e0186421.
PubMed

LI S, Liu S, Chen RA, Huang M, et al
Activation of the MKK3-p38-MK2-ZFP36 axis by coronavirus infection restricts the upregulation of AU-rich element-containing transcripts in proinflammatory response.
J Virol. 2022 Jan 5:jvi0208621. doi: 10.1128/jvi.02086.
PubMed Abstract available

December 2021

HUANG Y, Skarlupka AL, Jang H, Blas-Machado U, et al
SARS-CoV-2 and Influenza A virus Co-infections in Ferrets.
J Virol. 2021 Dec 22:JVI0179121. doi: 10.1128/JVI.01791.
PubMed Abstract available

OLIVARRIA GM, Cheng Y, Furman S, Pachow C, et al
Microglia do not restrict SARS-CoV-2 replication following infection of the central nervous system of K18-hACE2 transgenic mice.
J Virol. 2021 Dec 22:jvi0196921. doi: 10.1128/jvi.01969.
PubMed Abstract available

ETTICH J, Werner J, Weitz HT, Mueller E, et al
A hybrid soluble gp130/spike-nanobody fusion protein simultaneously blocks IL-6 trans-signaling and cellular infection with SARS-CoV2.
J Virol. 2021 Dec 22:JVI0162221. doi: 10.1128/JVI.01622.
PubMed Abstract available

NELSON M, O'Brien LM, Davies C, Keyser E, et al
Comparison of experimental MERS-CoV infection acquired by three individual routes of infection in the common marmoset.
J Virol. 2021 Dec 15:JVI0173921. doi: 10.1128/JVI.01739.
PubMed Abstract available

CAO K, Wang X, Peng H, Ding L, et al
A Single Vaccine Protects against SARS-CoV-2 and Influenza Virus in Mice.
J Virol. 2021 Dec 15:JVI0157821. doi: 10.1128/JVI.01578.
PubMed Abstract available

SHI J, Shi Y, Xiu R, Wang G, et al
Identification of a novel neutralizing epitope on the N-terminal domain of the HCoV-229E spike protein.
J Virol. 2021 Dec 15:JVI0195521. doi: 10.1128/JVI.01955.
PubMed Abstract available

ZHANG Y, Yan Q, Luo K, He P, et al
Analysis of B cell receptor repertoires reveals key signatures of systemic B cell response after SARS-CoV-2 infection.
J Virol. 2021 Dec 8:JVI0160021. doi: 10.1128/JVI.01600.
PubMed Abstract available

MALICOAT J, Manivasagam S, Zuniga S, Sola I, et al
Development of a Single-cycle Infectious SARS-CoV-2 Virus Replicon Particle System for use in BSL2 Laboratories.
J Virol. 2021 Dec 1:JVI0183721. doi: 10.1128/JVI.01837.
PubMed Abstract available

November 2021

TAKAMATSU Y, Imai M, Maeda K, Nakajima N, et al
Highly Neutralizing COVID-19 Convalescent Plasmas Potently Block SARS-CoV-2 Replication and Pneumonia in Syrian Hamsters.
J Virol. 2021 Nov 24:JVI0155121. doi: 10.1128/JVI.01551.
PubMed Abstract available

ZHANG S, Go EP, Ding H, Anang S, et al
Glycosylation and disulfide bonding of wild-type SARS-CoV-2 spike glycoprotein.
J Virol. 2021 Nov 24:JVI0162621. doi: 10.1128/JVI.01626.
PubMed Abstract available

UJIKE M, Etoh Y, Urushiyama N, Taguchi F, et al
Reverse Genetics with a Full-length Infectious cDNA Clone of Bovine Torovirus.
J Virol. 2021 Nov 24:JVI0156121. doi: 10.1128/JVI.01561.
PubMed Abstract available

MARTINS M, Fernandes MHV, Joshi LR, Diel DG, et al
Age-related susceptibility of ferrets to SARS-CoV-2 infection.
J Virol. 2021 Nov 24:JVI0145521. doi: 10.1128/JVI.01455.
PubMed Abstract available

BURCKHARDT RM, Dennehy JJ, Poon LLM, Saif LJ, et al
Are COVID-19 Vaccine Boosters Needed? The Science behind Boosters.
J Virol. 2021 Nov 24:JVI0197321. doi: 10.1128/JVI.01973.
PubMed Abstract available

LI Y, Jin Y, Kuang L, Luo Z, et al
The N-terminal Region of Middle East Respiratory Syndrome Coronavirus Accessory Protein 8b is Essential for Enhanced Virulence of an Attenuated Murine Coronavirus.
J Virol. 2021 Nov 24:JVI0184221. doi: 10.1128/JVI.01842.
PubMed Abstract available

LIU Y, Wang B, Liang QZ, Shi FS, et al
Roles of Two Major Domains of the Porcine Deltacoronavirus S1 Subunit in Receptor Binding and Neutralization.
J Virol. 2021;95:e0111821.
PubMed Abstract available

HEMSATH JR, Liaci AM, Rubin JD, Parrett BJ, et al
Ex Vivo and In Vivo CD46 Receptor Utilization by Species D Human Adenovirus Serotype 26 (HAdV26).
J Virol. 2021 Nov 17:JVI0082621. doi: 10.1128/JVI.00826.
PubMed Abstract available

BASU A, Penumutchu S, Nguyen K, Mbonye U, et al
A structurally conserved RNA element within SARS-CoV-2 ORF1a RNA and S mRNA regulates translation in response to viral S protein-induced signaling in human lung cells.
J Virol. 2021 Nov 10:JVI0167821. doi: 10.1128/JVI.01678.
PubMed Abstract available

LAMARCA AP, de Almeida LGP, da Silva Francisco Junior R, Cavalcante L, et al
Genomic Surveillance Tracks the First Community Outbreak of the SARS-CoV-2 Delta (B.1.617.2) Variant in Brazil.
J Virol. 2021 Nov 3:JVI0122821. doi: 10.1128/JVI.01228.
PubMed Abstract available

October 2021

YU J, Collins ND, Mercado NB, McMahan K, et al
Protective Efficacy of Gastrointestinal SARS-CoV-2 Delivery Against Intranasal and Intratracheal SARS-CoV-2 Challenge in Rhesus Macaques.
J Virol. 2021 Oct 27:JVI0159921. doi: 10.1128/JVI.01599.
PubMed Abstract available

SHARMA L, Peng X, Qing H, Hilliard BK, et al
Distinct Roles of Type I and Type III Interferons During a Native Murine beta Coronavirus Lung Infection.
J Virol. 2021 Oct 27:JVI0124121. doi: 10.1128/JVI.01241.
PubMed Abstract available

YAN B, Chakravorty S, Mirabelli C, Wang L, et al
Reply to Grigoriev et al., "Sequences of SARS-CoV-2 "Hybrids" with the Human Genome: Signs 1 of Non-coding RNA?"
J Virol. 2021 Oct 27:JVI0169021. doi: 10.1128/JVI.01690.
PubMed Abstract available

GRIGORIEV A, Kelley JJ, Guan L
Sequences of SARS-CoV-2 "Hybrids" with the Human Genome: Signs of Non-coding RNA?
J Virol. 2021 Oct 27:JVI0146221. doi: 10.1128/JVI.01462.
PubMed Abstract available

SIDDIQ MM, Chan AT, Miorin L, Yadaw AS, et al
Functional Effects of Cardiomyocyte Injury in COVID-19.
J Virol. 2021 Oct 20:JVI0106321. doi: 10.1128/JVI.01063.
PubMed Abstract available

WINKLER ES, Chen RE, Alam F, Yildiz S, et al
SARS-CoV-2 causes lung infection without severe disease in human ACE2 knock-in mice.
J Virol. 2021 Oct 20:JVI0151121. doi: 10.1128/JVI.01511.
PubMed Abstract available

DONG W, Mead H, Tian L, Park JG, et al
The K18-hACE2 Transgenic Mouse Model Recapitulates Non-Severe and Severe COVID-19 in Response to Infectious Dose of SARS-CoV-2 Virus.
J Virol. 2021 Oct 20:JVI0096421. doi: 10.1128/JVI.00964.
PubMed Abstract available

LUSVARGHI S, Wang W, Herrup R, Neerukonda SN, et al
Key substitutions in the spike protein of SARS-CoV-2 variants can predict resistance to monoclonal antibodies, but other substitutions can modify the effects.
J Virol. 2021 Oct 20:JVI0111021. doi: 10.1128/JVI.01110.
PubMed Abstract available

REN W, Zhu Y, Lan J, Chen H, et al
Susceptibilities of human ACE2 genetic variants in coronavirus infection.
J Virol. 2021 Oct 20:JVI0149221. doi: 10.1128/JVI.01492.
PubMed Abstract available

CHU HF, Cheng SC, Sun CY, Chou CY, et al
Structural and Biochemical Characterization of PEDV Papain-like Protease 2.
J Virol. 2021 Oct 13:JVI0137221. doi: 10.1128/JVI.01372.
PubMed Abstract available

SHI J, Li Z, Xu R, Zhang J, et al
The PERK/PKR-eIF2alpha pathway negatively regulates porcine hemagglutinating encephalomyelitis virus replication by attenuating global protein translation and facilitating stress granule formation.
J Virol. 2021 Oct 13:JVI0169521. doi: 10.1128/JVI.01695.
PubMed Abstract available

NAVARATNARAJAH CK, Pease DR, Halfmann P, Taye B, et al
Highly efficient SARS-CoV-2 infection of human cardiomyocytes: spike protein-mediated cell fusion and its inhibition.
J Virol. 2021 Oct 6:JVI0136821. doi: 10.1128/JVI.01368.
PubMed Abstract available

September 2021

SHUE B, Chiramel AI, Cerikan B, To TH, et al
Genome-wide CRISPR screen identifies RACK1 as a critical host factor for flavivirus replication.
J Virol. 2021 Sep 29:JVI0059621. doi: 10.1128/JVI.00596.
PubMed Abstract available

SIEGERS JY, Dhanasekaran V, Xie R, Deng YM, et al
Genetic and Antigenic Characterization of an Influenza A(H3N2) Outbreak in Cambodia and the Greater Mekong Subregion during the COVID-19 Pandemic, 2020.
J Virol. 2021 Sep 29:JVI0126721. doi: 10.1128/JVI.01267.
PubMed Abstract available

KIM YJ, Witwit H, Cubitt B, de la Torre JC, et al
Inhibitors of anti-apoptotic Bcl-2 family proteins exhibit potent and broad-spectrum anti-mammarenavirus activity via cell cycle arrest at G0/G1 phase.
J Virol. 2021 Sep 29:JVI0139921. doi: 10.1128/JVI.01399.
PubMed Abstract available

FANG P, Zhang J, Zhang H, Xia S, et al
Porcine deltacoronavirus enters porcine IPI-2I intestinal epithelial cells via macropinocytosis and clathrin-mediated endocytosis dependent on pH and dynamin.
J Virol. 2021 Sep 29:JVI0134521. doi: 10.1128/JVI.01345.
PubMed Abstract available

ZHANG Y, Gao H, Hu X, Wang Q, et al
Structure-based discovery and structural basis of a novel broad-spectrum natural product against main protease of coronavirus.
J Virol. 2021 Sep 29:JVI0125321. doi: 10.1128/JVI.01253.
PubMed Abstract available

PELZ L, Rudiger D, Dogra T, Alnaji FG, et al
Semi-continuous propagation of influenza A virus and its defective interfering particles: analyzing the dynamic competition to select candidates for antiviral therapy.
J Virol. 2021 Sep 22:JVI0117421. doi: 10.1128/JVI.01174.
PubMed Abstract available

ACHARYA A, Pandey K, Thurman M, Klug E, et al
Discovery and evaluation of entry inhibitors for SARS-CoV-2 and its emerging variants.
J Virol. 2021 Sep 22:JVI0143721. doi: 10.1128/JVI.01437.
PubMed Abstract available

SHANG C, Zhuang X, Zhang H, Li Y, et al
Inhibition of autophagy suppresses SARS-CoV-2 replication and ameliorates pneumonia in hACE2 transgenic mice and xenografted human lung tissues.
J Virol. 2021 Sep 22:JVI0153721. doi: 10.1128/JVI.01537.
PubMed Abstract available

QIAN Y, Lei T, Patel PS, Lee CH, et al
Direct activation of endothelial cells by SARS-CoV-2 nucleocapsid protein is blocked by Simvastatin.
J Virol. 2021 Sep 22:JVI0139621. doi: 10.1128/JVI.01396.
PubMed Abstract available

CHOI A, Koch M, Wu K, Dixon G, et al
Serum Neutralizing Activity of mRNA-1273 Against SARS-CoV-2 Variants.
J Virol. 2021 Sep 22:JVI0131321. doi: 10.1128/JVI.01313.
PubMed Abstract available

TOSTANOSKI LH, Gralinski LE, Martinez DR, Schaefer A, et al
Protective efficacy of rhesus adenovirus COVID-19 vaccines against mouse-adapted SARS-CoV-2.
J Virol. 2021 Sep 15:JVI0097421. doi: 10.1128/JVI.00974.
PubMed Abstract available

NILSSON-PAYANT BE, Uhl S, Grimont A, Doane AS, et al
The NF-kappaB transcriptional footprint is essential for SARS-CoV-2 replication.
J Virol. 2021 Sep 15:JVI0125721. doi: 10.1128/JVI.01257.
PubMed Abstract available

CHEN HY, Huang C, Tian L, Huang X, et al
Cytoplasmic tail truncation of SARS-CoV-2 Spike protein enhances titer of pseudotyped vectors but masks the effect of the D614G mutation.
J Virol. 2021 Sep 8:JVI0096621. doi: 10.1128/JVI.00966.
PubMed Abstract available

CHIEM K, Morales Vasquez D, Silvas JA, Park JG, et al
A bifluorescent-based assay for the identification of neutralizing antibodies against SARS-CoV-2 variants of concern in vitro and in vivo.
J Virol. 2021 Sep 8:JVI0112621. doi: 10.1128/JVI.01126.
PubMed Abstract available

ANDRADE ACDSP, Gabriel Campolina-Silva H, Queiroz-Junior CM, de Oliveira LC, et al
A biosafety level-2 mouse model for studying betacoronavirus-induced acute lung damage and systemic manifestations.
J Virol. 2021 Sep 8:JVI0127621. doi: 10.1128/JVI.01276.
PubMed Abstract available

August 2021

LI X, Wang L, Liu P, Li H, et al
A novel potentially recombinant rodent coronavirus with a polybasic cleavage site in the spike protein.
J Virol. 2021 Aug 25:JVI0117321. doi: 10.1128/JVI.01173.
PubMed Abstract available

SHILIAEV N, Lukash T, Palchevska O, Crossman DK, et al
Natural isolate and recombinant SARS-CoV-2 rapidly evolve in vitro to higher infectivity through more efficient binding to heparan sulfate and reduced S1/S2 cleavage.
J Virol. 2021 Aug 18:JVI0135721. doi: 10.1128/JVI.01357.
PubMed Abstract available

YANG YL, Liu J, Wang TY, Chen M, et al
Aminopeptidase N is an entry co-factor triggering porcine deltacoronavirus entry via an endocytotic pathway.
J Virol. 2021 Aug 18:JVI0094421. doi: 10.1128/JVI.00944.
PubMed Abstract available

WANG G, Hu G, Liang R, Shi J, et al
Establishment of Full-length cDNA Clones and an Efficient Oral Infection Model for Feline Coronavirus in Cats.
J Virol. 2021 Aug 18:JVI0074521. doi: 10.1128/JVI.00745.
PubMed Abstract available

KREUTZBERGER AJB, Sanyal A, Ojha R, Pyle JD, et al
Synergistic block of SARS-CoV-2 infection by combined drug inhibition of the host entry factors PIKfyve kinase and TMPRSS2 protease.
J Virol. 2021 Aug 18:JVI0097521. doi: 10.1128/JVI.00975.
PubMed Abstract available

LU M, Zhang Y, Dravid P, Li A, et al
A methyltransferase-defective VSV-based SARS-CoV-2 vaccine candidate provides complete protection against SARS-CoV-2 infection in hamsters.
J Virol. 2021 Aug 11:JVI0059221. doi: 10.1128/JVI.00592.
PubMed Abstract available

July 2021

CANTWELL AM, Singh H, Platt M, Yu Y, et al
Kinetic multi-omic analysis of responses to SARS-CoV-2 infection in a model of severe COVID-19.
J Virol. 2021 Jul 28:JVI0101021. doi: 10.1128/JVI.01010.
PubMed Abstract available

LI Z, Gao F, Lan Y, Guan J, et al
Porcine Haemagglutinating Encephalomyelitis Virus Triggers Neural Autophagy Independent of ULK1.
J Virol. 2021 Jul 21:JVI0085121. doi: 10.1128/JVI.00851.
PubMed Abstract available

WANG H, Kong N, Jiao Y, Dong S, et al
EGR1 suppresses porcine epidemic diarrhea virus replication by regulating IRAV to degrade viral nucleocapsid protein.
J Virol. 2021 Jul 21:JVI0064521. doi: 10.1128/JVI.00645.
PubMed Abstract available

FERRARI M, Mekkaoui L, Ilca FT, Akbar Z, et al
Characterisation of a novel ACE2-based therapeutic with enhanced rather than reduced activity against SARS-CoV-2 variants.
J Virol. 2021 Jul 21:JVI0068521. doi: 10.1128/JVI.00685.
PubMed Abstract available

CHEN DY, Khan N, Close BJ, Goel RK, et al
SARS-CoV-2 disrupts proximal elements in the JAK-STAT pathway.
J Virol. 2021 Jul 14:JVI0086221. doi: 10.1128/JVI.00862.
PubMed Abstract available

XU J, Mao J, Han X, Shi F, et al
Porcine epidemic diarrhea virus inhibits HDAC1 expression to facilitate its replication via binding of its nucleocapsid protein to host transcription factor Sp1.
J Virol. 2021 Jul 7:JVI0085321. doi: 10.1128/JVI.00853.
PubMed Abstract available

June 2021

NGUYEN HT, Falzarano D, Gerdts V, Liu Q, et al
Construction of a non-infectious SARS-CoV-2 replicon for antiviral drug testing and gene function studies.
J Virol. 2021 Jun 30:JVI0068721. doi: 10.1128/JVI.00687.
PubMed Abstract available

SUN G, Sui Y, Zhou Y, Ya J, et al
Structural basis of covalent inhibitory mechanism of TMPRSS2-related serine proteases by camostat.
J Virol. 2021 Jun 23:JVI0086121. doi: 10.1128/JVI.00861.
PubMed Abstract available

MEYER K, Patra T, Vijayamahantesh, Ray R, et al
SARS-CoV-2 spike protein induces paracrine senescence and leukocyte adhesionin endothelial cells.
J Virol. 2021 Jun 23:JVI0079421. doi: 10.1128/JVI.00794.
PubMed Abstract available

SILVAS JA, Morales Vasquez D, Park JG, Chiem K, et al
Contribution of SARS-CoV-2 accessory proteins to viral pathogenicity in K18 hACE2 transgenic mice.
J Virol. 2021 Jun 16:JVI0040221. doi: 10.1128/JVI.00402.
PubMed Abstract available

LI A, Zhao K, Zhang B, Hua R, et al
SARS-CoV-2 NSP12 protein is not an IFN-beta antagonist.
J Virol. 2021 Jun 16:JVI0074721. doi: 10.1128/JVI.00747.
PubMed Abstract available

KUMAR A, Ishida R, Strilets T, Cole J, et al
SARS-CoV-2 Nonstructural Protein 1 Inhibits the Interferon Response by Causing Depletion of Key Host Signaling Factors.
J Virol. 2021;95:e0026621.
PubMed Abstract available

HAYASHI Y, Tsuchiya K, Yamamoto M, Nemoto-Sasaki Y, et al
N-(4-Hydroxyphenyl) retinamide suppresses SARS-CoV-2 spike protein-mediated cell-cell fusion by a dihydroceramide Delta4-desaturase 1-independent mechanism.
J Virol. 2021 Jun 9:JVI0080721. doi: 10.1128/JVI.00807.
PubMed Abstract available

WANG X, Zhao Y, Yan F, Wang T, et al
Viral and host transcriptomes in SARS-CoV-2 infected human lung cells.
J Virol. 2021 Jun 9:JVI0060021. doi: 10.1128/JVI.00600.
PubMed Abstract available

QIN Y, Tu K, Teng Q, Feng D, et al
Identification of novel T-cell epitopes on infectious bronchitis virus N protein and development of a multi-epitope vaccine.
J Virol. 2021 Jun 9:JVI0066721. doi: 10.1128/JVI.00667.
PubMed Abstract available

OU J, Zhou Z, Dai R, Zhang J, et al
V367F mutation in SARS-CoV-2 spike RBD emerging during the early transmission phase enhances viral infectivity through increased human ACE2 receptor binding affinity.
J Virol. 2021 Jun 2:JVI0061721. doi: 10.1128/JVI.00617.
PubMed Abstract available

May 2021

SU M, Shi D, Xing X, Qi S, et al
Coronavirus PEDV nucleocapsid protein interacts with p53 to induce cell cycle arrest in S-phase and promotes viral replication.
J Virol. 2021 May 26:JVI0018721. doi: 10.1128/JVI.00187.
PubMed Abstract available

LATOURRETTE K, Holste NM, Rodriguez-Pena R, Leme RA, et al
Genome-wide variation in betacoronaviruses.
J Virol. 2021 May 26:JVI0049621. doi: 10.1128/JVI.00496.
PubMed Abstract available

DOSTALIK P, Krafcikova P, Silhan J, Kozic J, et al
Structural analysis of the OC43 coronavirus 2'-O-RNA methyltransferase.
J Virol. 2021 May 19. pii: JVI.00463-21. doi: 10.1128/JVI.00463.
PubMed Abstract available

VOTH LS, O'Connor JJ, Kerr CM, Doerger E, et al
Unique mutations in the MHV macrodomain differentially attenuate virus replication, indicating multiple roles for the macrodomain in coronavirus replication.
J Virol. 2021 May 19. pii: JVI.00766-21. doi: 10.1128/JVI.00766.
PubMed Abstract available

YAN B, Chakravorty S, Mirabelli C, Wang L, et al
Host-virus chimeric events in SARS-CoV2 infected cells are infrequent and artifactual.
J Virol. 2021 May 12. pii: JVI.00294-21. doi: 10.1128/JVI.00294.
PubMed Abstract available

CARNELL GW, Ciazynska KA, Wells DA, Xiong X, et al
SARS-CoV-2 spike protein stabilized in the closed state induces potent neutralizing responses.
J Virol. 2021 May 7. pii: JVI.00203-21. doi: 10.1128/JVI.00203.
PubMed Abstract available

TRIBOLET L, Alexander MR, Brice AM, van Vuren PJ, et al
ILRUN downregulates ACE2 expression and blocks infection of human cells by SARS-CoV-2.
J Virol. 2021 May 7. pii: JVI.00327-21. doi: 10.1128/JVI.00327.
PubMed Abstract available

LULLA V, Wandel MP, Bandyra KJ, Ulferts R, et al
Targeting the conserved stem loop 2 motif in the SARS-CoV-2 genome.
J Virol. 2021 May 7. pii: JVI.00663-21. doi: 10.1128/JVI.00663.
PubMed Abstract available

LEE W, Kingstad-Bakke B, Kedl RM, Kawaoka Y, et al
CCR2 Regulates Vaccine-Induced Mucosal T-Cell Memory to Influenza A Virus.
J Virol. 2021 May 5. pii: JVI.00530-21. doi: 10.1128/JVI.00530.
PubMed Abstract available

April 2021

RESNICK SJ, Iketani S, Hong SJ, Zask A, et al
Inhibitors of coronavirus 3CL proteases protect cells from protease-mediated cytotoxicity.
J Virol. 2021 Apr 28. pii: JVI.02374-20. doi: 10.1128/JVI.02374.
PubMed Abstract available

ALFI O, Yakirevitch A, Wald O, Wandel O, et al
Human nasal and lung tissues infected ex vivo with SARS-CoV-2 provide insights into differential tissue-specific and virus-specific innate immune responses in the upper and lower respiratory tract.
J Virol. 2021 Apr 23. pii: JVI.00130-21. doi: 10.1128/JVI.00130.
PubMed Abstract available

VIDAL SJ, Collier AY, Yu J, McMahan K, et al
Correlates of Neutralization Against SARS-CoV-2 Variants of Concern by Early Pandemic Sera.
J Virol. 2021 Apr 23. pii: JVI.00404-21. doi: 10.1128/JVI.00404.
PubMed Abstract available

VERMA D, Mel Church T, Swaminathan S
Epstein-Barr virus lytic replication induces ACE2 expression and enhances SARS CoV-2 pseudotyped virus entry in epithelial cells.
J Virol. 2021 Apr 14. pii: JVI.00192-21. doi: 10.1128/JVI.00192.
PubMed Abstract available

PATEL DR, Field CJ, Septer KM, Sim DG, et al
Transmission and protection against re-infection in the ferret model with the SARS-CoV-2 USA-WA1/2020 reference isolate.
J Virol. 2021 Apr 7. pii: JVI.02232-20. doi: 10.1128/JVI.02232.
PubMed Abstract available

March 2021

LIU W, Reyes HM, Yang JF, Li Y, et al
Activation of STING signaling pathway effectively blocks human coronavirus infection.
J Virol. 2021 Mar 31. pii: JVI.00490-21. doi: 10.1128/JVI.00490.
PubMed Abstract available

TOMITA Y, Matsuyama S, Fukuhara H, Maenaka K, et al
The physiological TMPRSS2 inhibitor HAI-2 alleviates SARS-CoV-2 infection.
J Virol. 2021 Mar 31. pii: JVI.00434-21. doi: 10.1128/JVI.00434.
PubMed Abstract available

MORA-DIAZ JC, Pineyro PE, Rauh R, Nelson W, et al
Porcine hemagglutinating encephalomyelitis virus infection in vivo and ex vivo.
J Virol. 2021 Mar 24. pii: JVI.02335-20. doi: 10.1128/JVI.02335.
PubMed Abstract available

YU J, Li Z, He X, Gebre MS, et al
Deletion of the SARS-CoV-2 Spike Cytoplasmic Tail Increases Infectivity in Pseudovirus Neutralization Assays.
J Virol. 2021 Mar 16. pii: JVI.00044-21. doi: 10.1128/JVI.00044.
PubMed Abstract available

CHENG J, Zhao Y, Hu Y, Zhao J, et al
The furin-S2' site in avian coronavirus plays a key role in central nervous system damage progression.
J Virol. 2021 Mar 16. pii: JVI.02447-20. doi: 10.1128/JVI.02447.
PubMed Abstract available

MA J, Su D, Sun Y, Huang X, et al
Cryo-EM structure of S-Trimer, a subunit vaccine candidate for COVID-19.
J Virol. 2021 Mar 10. pii: JVI.00194-21. doi: 10.1128/JVI.00194.
PubMed Abstract available

ZHANG Y, Huang K, Wang T, Deng F, et al
SARS-CoV-2 rapidly adapts in aged BALB/c mice and induces typical pneumonia.
J Virol. 2021 Mar 10. pii: JVI.02477-20. doi: 10.1128/JVI.02477.
PubMed Abstract available

PALMER MV, Martins M, Falkenberg S, Buckley A, et al
Susceptibility of white-tailed deer (Odocoileus virginianus) to SARS-CoV-2.
J Virol. 2021 Mar 10. pii: JVI.00083-21. doi: 10.1128/JVI.00083.
PubMed Abstract available

JACOB-DOLAN C, Feldman J, McMahan K, Yu J, et al
Coronavirus-Specific Antibody Cross Reactivity in Rhesus Macaques Following SARS-CoV-2 Vaccination and Infection.
J Virol. 2021 Mar 10. pii: JVI.00117-21. doi: 10.1128/JVI.00117.
PubMed Abstract available

LIU S, Selvaraj P, Lien CZ, Nunez IA, et al
The PRRA insert at the S1/S2 site modulates cellular tropism of SARS-CoV-2 and ACE2 usage by the closely related Bat RaTG13.
J Virol. 2021 Mar 8. pii: JVI.01751-20. doi: 10.1128/JVI.01751.
PubMed Abstract available

MA H, Zeng W, Meng X, Huang X, et al
Potent Neutralization of SARS-CoV-2 by Hetero-bivalent Alpaca Nanobodies Targeting the Spike Receptor-Binding Domain.
J Virol. 2021 Mar 3. pii: JVI.02438-20. doi: 10.1128/JVI.02438.
PubMed Abstract available

VOLOCH CM, da Silva Francisco R Jr, de Almeida LGP, Cardoso CC, et al
Genomic characterization of a novel SARS-CoV-2 lineage from Rio de Janeiro, Brazil.
J Virol. 2021 Mar 1. pii: JVI.00119-21. doi: 10.1128/JVI.00119.
PubMed Abstract available

February 2021

DEINHARDT-EMMER S, Bottcher S, Haring C, Giebeler L, et al
SARS-CoV-2 causes severe epithelial inflammation and barrier dysfunction.
J Virol. 2021 Feb 26. pii: JVI.00110-21. doi: 10.1128/JVI.00110.
PubMed Abstract available

LE COUPANEC A, Desforges M, Kaufer B, Dubeau P, et al
Potential differences in cleavage of the S protein and type-1 interferon together control human coronavirus infection, propagation, and neuropathology within the central nervous system.
J Virol. 2021 Feb 24. pii: JVI.00140-21. doi: 10.1128/JVI.00140.
PubMed Abstract available

DHAKAL S, Loube J, Misplon JA, Lo CY, et al
Effect of an adenovirus-vectored universal influenza virus vaccine on pulmonary pathophysiology in a mouse model.
J Virol. 2021 Feb 24. pii: JVI.02359-20. doi: 10.1128/JVI.02359.
PubMed Abstract available

DE VRIES M, Mohamed AS, Prescott RA, Valero-Jimenez AM, et al
A comparative analysis of SARS-CoV-2 antivirals characterizes 3CL(pro) inhibitor PF-00835231 as a potential new treatment for COVID-19.
J Virol. 2021 Feb 23. pii: JVI.01819-20. doi: 10.1128/JVI.01819.
PubMed Abstract available

HORNICH BF, Grosskopf AK, Schlagowski S, Tenbusch M, et al
SARS-CoV-2 and SARS-CoV spike-mediated cell-cell fusion differ in the requirements for receptor expression and proteolytic activation.
J Virol. 2021 Feb 19. pii: JVI.00002-21. doi: 10.1128/JVI.00002.
PubMed Abstract available

SUN L, Chen H, Ming X, Bo Z, et al
Porcine Epidemic Diarrhea Virus Infection Induces Caspase-8 mediated G3BP1 Cleavage and Subverts Stress Granules to Promote Viral Replication.
J Virol. 2021 Feb 10. pii: JVI.02344-20. doi: 10.1128/JVI.02344.
PubMed Abstract available

WINSTONE H, Lista MJ, Reid AC, Bouton C, et al
The polybasic cleavage site in the SARS-CoV-2 spike modulates viral sensitivity to Type I interferon and IFITM2.
J Virol. 2021 Feb 9. pii: JVI.02422-20. doi: 10.1128/JVI.02422.
PubMed Abstract available

January 2021

REBENDENNE A, Valadao ALC, Tauziet M, Maarifi G, et al
SARS-CoV-2 triggers an MDA-5-dependent interferon response which is unable to control replication in lung epithelial cells.
J Virol. 2021 Jan 29. pii: JVI.02415-20. doi: 10.1128/JVI.02415.
PubMed Abstract available

DAGOTTO G, Mercado NB, Martinez DR, Hou YJ, et al
Comparison of Subgenomic and Total RNA in SARS-CoV-2 Challenged Rhesus Macaques.
J Virol. 2021 Jan 20. pii: JVI.02370-20. doi: 10.1128/JVI.02370.
PubMed Abstract available

DOMINGO E, Perales C
The time for COVID-19 vaccination.
J Virol. 2021 Jan 19. pii: JVI.02437-20. doi: 10.1128/JVI.02437.
PubMed Abstract available

CHEN JS, Alfajaro MM, Chow RD, Wei J, et al
Non-steroidal anti-inflammatory drugs dampen the cytokine and antibody response to SARS-CoV-2 infection.
J Virol. 2021 Jan 13. pii: JVI.00014-21. doi: 10.1128/JVI.00014.
PubMed Abstract available

CHIEM K, Morales Vasquez D, Park JG, Platt RN, et al
Generation and Characterization of recombinant SARS-CoV-2 expressing reporter genes.
J Virol. 2021 Jan 11. pii: JVI.02209-20. doi: 10.1128/JVI.02209.
PubMed Abstract available

SHI Y, Shi J, Sun L, Tan Y, et al
Insight into vaccine development for Alpha-coronaviruses based on structural and immunological analyses of spike proteins.
J Virol. 2021 Jan 7. pii: JVI.02284-20. doi: 10.1128/JVI.02284.
PubMed Abstract available

GARCIA-ARRIAZA J, Garaigorta U, Perez P, Lazaro-Frias A, et al
COVID-19 vaccine candidates based on modified vaccinia virus Ankara expressing the SARS-CoV-2 spike induce robust T- and B-cell immune responses and full efficacy in mice.
J Virol. 2021 Jan 7. pii: JVI.02260-20. doi: 10.1128/JVI.02260.
PubMed Abstract available

December 2020

ZHAO J, Sun L, Zhao Y, Feng D, et al
Coronavirus Endoribonuclease Ensures Efficient Viral Replication and Prevents Protein Kinase R Activation.
J Virol. 2020 Dec 23. pii: JVI.02103-20. doi: 10.1128/JVI.02103.
PubMed Abstract available

LEE E, Sandgren K, Duette G, Stylianou VV, et al
Identification of SARS-CoV-2 Nucleocapsid and Spike T-cell Epitopes for Assessing T-cell Immunity.
J Virol. 2020 Dec 21. pii: JVI.02002-20. doi: 10.1128/JVI.02002.
PubMed Abstract available

NGUYEN HT, Zhang S, Wang Q, Anang S, et al
Spike glycoprotein and host cell determinants of SARS-CoV-2 entry and cytopathic effects.
J Virol. 2020 Dec 11. pii: JVI.02304-20. doi: 10.1128/JVI.02304.
PubMed Abstract available

TAKAGI A, Matsui M
Identification of HLA-A*02:01-restricted candidate epitopes derived from the non-structural polyprotein 1a of SARS-CoV-2 that may be natural targets of CD8(+) T cell recognition in vivo.
J Virol. 2020 Dec 2. pii: JVI.01837-20. doi: 10.1128/JVI.01837.
PubMed Abstract available

TAVARES RCA, Mahadeshwar G, Wan H, Huston NC, et al
The global and local distribution of RNA structure throughout the SARS-CoV-2 genome.
J Virol. 2020 Dec 2. pii: JVI.02190-20. doi: 10.1128/JVI.02190.
PubMed Abstract available

November 2020

PAHMEIER F, Neufeldt CJ, Cerikan B, Prasad V, et al
A Versatile Reporter System to Monitor Virus Infected Cells and Its Application to Dengue Virus and SARS-CoV-2.
J Virol. 2020 Nov 30. pii: JVI.01715-20. doi: 10.1128/JVI.01715.
PubMed Abstract available

YUAN LX, Liang JQ, Zhu QC, Dai G, et al
Gammacoronavirus Avian Infectious Bronchitis Virus and Alphacoronavirus Porcine Epidemic Diarrhea Virus Exploit a Cell-Survival Strategy via Upregulation of cFOS to Promote Viral Replication.
J Virol. 2020 Nov 25. pii: JVI.02107-20. doi: 10.1128/JVI.02107.
PubMed Abstract available

WESTERGREN JAKOBSSON A, Segerman B, Wallerman O, Lind SB, et al
The Human Adenovirus Type 2 Transcriptome: An Amazing Complexity of Alternatively Spliced mRNAs.
J Virol. 2020 Nov 25. pii: JVI.01869-20. doi: 10.1128/JVI.01869.
PubMed Abstract available

CLARK LK, Green TJ, Petit CM
Structure of nonstructural protein 1 from SARS-CoV-2.
J Virol. 2020 Nov 24. pii: JVI.02019-20. doi: 10.1128/JVI.02019.
PubMed Abstract available

MILEWSKA A, Chi Y, Szczepanski A, Barreto-Duran E, et al
HTCC as a Polymeric Inhibitor of SARS-CoV-2 and MERS-CoV.
J Virol. 2020 Nov 20. pii: JVI.01622-20. doi: 10.1128/JVI.01622.
PubMed Abstract available

UJIKE M, Kawachi Y, Matsunaga Y, Etho Y, et al
Characterization of localization and export signals of bovine torovirus nucleocapsid protein responsible for extensive nuclear and nucleolar accumulation and their importance for virus growth.
J Virol. 2020 Nov 11. pii: JVI.02111-20. doi: 10.1128/JVI.02111.
PubMed Abstract available

TANDON R, Sharp JS, Zhang F, Pomin VH, et al
Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives.
J Virol. 2020 Nov 10. pii: JVI.01987-20. doi: 10.1128/JVI.01987.
PubMed Abstract available

ALHAMMAD YMO, Kashipathy MM, Roy A, Gagne JP, et al
The SARS-CoV-2 conserved macrodomain is a mono-ADP-ribosylhydrolase.
J Virol. 2020 Nov 6. pii: JVI.01969-20. doi: 10.1128/JVI.01969.
PubMed Abstract available

FENWICK C, Croxatto A, Coste AT, Pojer F, et al
Changes in SARS-CoV-2 Spike versus Nucleoprotein Antibody Responses Impact the Estimates of Infections in Population-Based Seroprevalence Studies.
J Virol. 2020 Nov 3. pii: JVI.01828-20. doi: 10.1128/JVI.01828.
PubMed Abstract available

HEISE M, Dermody TS, Casadevall A, Sandri-Goldin RM, et al
The Decision to Publish Gutierrez-Alvarez et al., "Middle East Respiratory Syndrome Coronavirus Gene 5 Modulates Pathogenesis in Mice".
J Virol. 2020 Nov 3. pii: JVI.02118-20. doi: 10.1128/JVI.02118.
PubMed Abstract available

GUTIERREZ-ALVAREZ J, Wang L, Fernandez-Delgado R, Li K, et al
Middle East Respiratory Syndrome Coronavirus Gene 5 Modulates Pathogenesis in Mice.
J Virol. 2020 Nov 3. pii: JVI.01172-20. doi: 10.1128/JVI.01172.
PubMed Abstract available

October 2020

DIEZ-FUERTES F, Iglesias-Caballero M, Garcia Perez J, Monzon S, et al
A FOUNDER EFFECT LED EARLY SARS-COV-2 TRANSMISSION IN SPAIN.
J Virol. 2020 Oct 30. pii: JVI.01583-20. doi: 10.1128/JVI.01583.
PubMed Abstract available

MATSUYAMA S, Kawase M, Nao N, Shirato K, et al
The inhaled steroid ciclesonide blocks SARS-CoV-2 RNA replication by targeting the viral replication-transcription complex in cultured cells.
J Virol. 2020 Oct 14. pii: JVI.01648-20. doi: 10.1128/JVI.01648.
PubMed Abstract available

LI Y, Yang N, Chen J, Huang X, et al
Next-Generation Porcine Intestinal Organoids: an Apical-Out Organoid Model for Swine Enteric Virus Infection and Immune Response Investigations.
J Virol. 2020;94.
PubMed Abstract available

September 2020

SYAGE AR, Ekiz HA, Skinner DD, Stone C, et al
Single-cell RNA sequencing reveals the diversity of the immunological landscape following CNS infection by a murine coronavirus.
J Virol. 2020 Sep 30. pii: JVI.01295-20. doi: 10.1128/JVI.01295.
PubMed Abstract available

HU Y, Li W, Gao T, Cui Y, et al
Correction for Hu et al., "The Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Inhibits Type I Interferon Production by Interfering with TRIM25-Mediated RIG-I Ubiquitination".
J Virol. 2020;94.
PubMed

XU S, Zhou J, Chen Y, Tong X, et al
Characterization of Self-Processing Activities and Substrate Specificities of Porcine Torovirus 3C-Like Protease.
J Virol. 2020;94.
PubMed Abstract available

CHOI JA, Goo J, Yang E, Jung DI, et al
Cross-Protection against MERS-CoV by Prime-Boost Vaccination Using Viral Spike DNA and Protein.
J Virol. 2020 Sep 23. pii: JVI.01176-20. doi: 10.1128/JVI.01176.
PubMed Abstract available

OGANDO NS, Zevenhoven-Dobbe JC, van der Meer Y, Bredenbeek PJ, et al
The enzymatic activity of the nsp14 exoribonuclease is critical for replication of MERS-CoV and SARS-CoV-2.
J Virol. 2020 Sep 16. pii: JVI.01246-20. doi: 10.1128/JVI.01246.
PubMed Abstract available

LOKUGAMAGE KG, Hage A, de Vries M, Valero-Jimenez AM, et al
Type I interferon susceptibility distinguishes SARS-CoV-2 from SARS-CoV.
J Virol. 2020 Sep 16. pii: JVI.01410-20. doi: 10.1128/JVI.01410.
PubMed Abstract available

CHANDRASEKAR SS, Kingstad-Bakke B, Wu CW, Suresh M, et al
A Novel Mucosal Adjuvant System for Immunization against Avian Coronavirus Causing Infectious Bronchitis.
J Virol. 2020;94.
PubMed Abstract available

BROCATO RL, Principe LM, Kim RK, Zeng X, et al
Disruption of Adaptive Immunity Enhances Disease in SARS-CoV-2 Infected Syrian Hamsters.
J Virol. 2020 Sep 8. pii: JVI.01683-20. doi: 10.1128/JVI.01683.
PubMed Abstract available

August 2020

LI Y, Wang H, Tang X, Fang S, et al
SARS-CoV-2 and three related coronaviruses utilize multiple ACE2 orthologs and are potently blocked by an improved ACE2-Ig.
J Virol. 2020 Aug 26. pii: JVI.01283-20. doi: 10.1128/JVI.01283.
PubMed Abstract available

FROGGATT HM, Heaton BE, Heaton NS
Development of a fluorescence based, high-throughput SARS-CoV-2 3CL(pro) reporter assay.
J Virol. 2020 Aug 25. pii: JVI.01265-20. doi: 10.1128/JVI.01265.
PubMed Abstract available

GUAN H, Wang Y, Perculija V, Saeed AFUH, et al
Cryo-electron microscopy structure of the SADS-CoV spike glycoprotein provides insights into an evolution of unique coronavirus spike proteins.
J Virol. 2020 Aug 19. pii: JVI.01301-20. doi: 10.1128/JVI.01301.
PubMed Abstract available

WESTON S, Coleman CM, Haupt R, Logue J, et al
Broad anti-coronaviral activity of FDA approved drugs against SARS-CoV-2 in vitro and SARS-CoV in vivo.
J Virol. 2020 Aug 19. pii: JVI.01218-20. doi: 10.1128/JVI.01218.
PubMed Abstract available

SI F, Chen B, Hu X, Yu R, et al
Porcine Epidemic Diarrhea Virus ORF3 Protein Is Transported through the Exocytic Pathway.
J Virol. 2020;94.
PubMed Abstract available

HWANG M, Bergmann CC
Neuronal ablation of IFNalpha/beta signaling exacerbates CNS viral dissemination and impairs IFNgamma responsiveness in microglia/macrophages.
J Virol. 2020 Aug 12. pii: JVI.00422-20. doi: 10.1128/JVI.00422.
PubMed Abstract available

JOHNSON MC, Lyddon TD, Suarez R, Salcedo B, et al
Optimized pseudotyping conditions for the SARS COV-2 Spike glycoprotein.
J Virol. 2020 Aug 11. pii: JVI.01062-20. doi: 10.1128/JVI.01062.
PubMed Abstract available

July 2020

GUO H, Hu BJ, Yang XL, Zeng LP, et al
Evolutionary arms race between virus and host drives genetic diversity in bat SARS related coronavirus spike genes.
J Virol. 2020 Jul 22. pii: JVI.00902-20. doi: 10.1128/JVI.00902.
PubMed Abstract available

VANDERHEIDEN A, Ralfs P, Chirkova T, Upadhyay AA, et al
Type I and Type III IFN Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.
J Virol. 2020 Jul 22. pii: JVI.00985-20. doi: 10.1128/JVI.00985.
PubMed Abstract available

WANG Y, Sun J, Li X, Zhu A, et al
Increased Pathogenicity and Virulence of Middle East Respiratory Syndrome Coronavirus Clade B In Vitro and In Vivo.
J Virol. 2020;94.
PubMed Abstract available

AHLEN G, Frelin L, Nekoyan N, Weber F, et al
The SARS-CoV-2 N protein is a good component in a vaccine.
J Virol. 2020 Jul 13. pii: JVI.01279-20. doi: 10.1128/JVI.01279.
PubMed Abstract available

ZHAO X, Chen D, Szabla R, Zheng M, et al
Broad and differential animal ACE2 receptor usage by SARS-CoV-2.
J Virol. 2020 Jul 13. pii: JVI.00940-20. doi: 10.1128/JVI.00940.
PubMed Abstract available

SMITH M, Honce R, Schultz-Cherry S
Metabolic Syndrome and Viral Pathogenesis: Lessons from Influenza and Coronaviruses.
J Virol. 2020 Jul 13. pii: JVI.00665-20. doi: 10.1128/JVI.00665.
PubMed Abstract available

TABOADA B, Vazquez-Perez JA, Munoz Medina JE, Ramos Cervantes P, et al
Genomic Analysis of Early SARS-CoV-2 Variants Introduced in Mexico.
J Virol. 2020 Jul 8. pii: JVI.01056-20. doi: 10.1128/JVI.01056.
PubMed Abstract available

ZHAO X, Zheng S, Chen D, Zheng M, et al
LY6E Restricts the Entry of Human Coronaviruses, Including the Currently Pandemic SARS-CoV-2.
J Virol. 2020 Jul 8. pii: JVI.00562-20. doi: 10.1128/JVI.00562.
PubMed Abstract available

DERVAS E, Hepojoki J, Smura T, Prahauser B, et al
Serpentoviruses, more than respiratory pathogens.
J Virol. 2020 Jul 8. pii: JVI.00649-20. doi: 10.1128/JVI.00649.
PubMed Abstract available

CHAKRAVARTY D, Saadi F, Kundu S, Bose A, et al
CD4 Deficiency Causes Poliomyelitis and Axonal Blebbing in Murine Coronavirus-Induced Neuroinflammation.
J Virol. 2020;94.
PubMed Abstract available

DALMANN A, Reimann I, Wernike K, Beer M, et al
Autonomously Replicating RNAs of Bungowannah Pestivirus: E(RNS) Is Not Essential for the Generation of Infectious Particles.
J Virol. 2020;94.
PubMed Abstract available

YIN L, Chen J, Li L, Guo S, et al
Aminopeptidase N Expression, Not Interferon Responses, Determines the Intestinal Segmental Tropism of Porcine Deltacoronavirus.
J Virol. 2020;94.
PubMed Abstract available

June 2020

MOORE JP, Klasse PJ
SARS-CoV-2 vaccines: 'Warp Speed' needs mind melds not warped minds.
J Virol. 2020 Jun 26. pii: JVI.01083-20. doi: 10.1128/JVI.01083.
PubMed Abstract available

LIU Z, Zheng H, Lin H, Li M, et al
Identification of common deletions in the spike protein of SARS-CoV-2.
J Virol. 2020 Jun 22. pii: JVI.00790-20. doi: 10.1128/JVI.00790.
PubMed Abstract available

DENG X, Buckley AC, Pillatzki A, Lager KM, et al
Inactivating Three Interferon Antagonists Attenuates Pathogenesis of an Enteric Coronavirus.
J Virol. 2020 Jun 17. pii: JVI.00565-20. doi: 10.1128/JVI.00565.
PubMed Abstract available

DUTTA NK, Mazumdar K, Gordy JT
The Nucleocapsid Protein of SARS-CoV-2: a Target for Vaccine Development.
J Virol. 2020;94.
PubMed

STRAUS MR, Tang T, Lai AL, Flegel A, et al
Ca(2+) Ions Promote Fusion of Middle East Respiratory Syndrome Coronavirus with Host Cells and Increase Infectivity.
J Virol. 2020;94.
PubMed Abstract available

CHANG CY, Liu HM, Chang MF, Chang SC, et al
Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Suppresses Type I and Type III Interferon Induction by Targeting RIG-I Signaling.
J Virol. 2020;94.
PubMed Abstract available

May 2020

LU Y, Cai H, Lu M, Ma Y, et al
Porcine epidemic diarrhea virus deficient in RNA cap guanine-N-7 methylation is attenuated and induces higher type I and III interferon responses.
J Virol. 2020 May 27. pii: JVI.00447-20. doi: 10.1128/JVI.00447.
PubMed Abstract available

ZHU X, Chen J, Tian L, Zhou Y, et al
Porcine Deltacoronavirus nsp5 Cleaves DCP1A to Decrease Its Antiviral Ability.
J Virol. 2020 May 27. pii: JVI.02162-19. doi: 10.1128/JVI.02162.
PubMed Abstract available

MILEWSKA A, Kula-Pacurar A, Wadas J, Suder A, et al
Replication of SARS-CoV-2 in human respiratory epithelium.
J Virol. 2020 May 20. pii: JVI.00957-20. doi: 10.1128/JVI.00957.
PubMed Abstract available

VOLK A, Hackbart M, Deng X, Cruz-Pulido Y, et al
Coronavirus Endoribonuclease and Deubiquitinating Interferon Antagonists Differentially Modulate the Host Response during Replication in Macrophages.
J Virol. 2020;94.
PubMed Abstract available

DENG X, Chen Y, Mielech AM, Hackbart M, et al
Structure-Guided Mutagenesis Alters Deubiquitinating Activity and Attenuates Pathogenesis of a Murine Coronavirus.
J Virol. 2020;94.
PubMed Abstract available

ZHAI X, Sun J, Yan Z, Zhang J, et al
Comparison of SARS-CoV-2 spike protein binding to ACE2 receptors from human, pets, farm animals, and putative intermediate hosts.
J Virol. 2020 May 13. pii: JVI.00831-20. doi: 10.1128/JVI.00831.
PubMed Abstract available

ZHU Y, Yu D, Yan H, Chong H, et al
Design of potent membrane fusion inhibitors against SARS-CoV-2, an emerging coronavirus with high fusogenic activity.
J Virol. 2020 May 6. pii: JVI.00635-20. doi: 10.1128/JVI.00635.
PubMed Abstract available

HOLLAND LA, Kaelin EA, Maqsood R, Estifanos B, et al
An 81 nucleotide deletion in SARS-CoV-2 ORF7a identified from sentinel surveillance in Arizona (Jan-Mar 2020).
J Virol. 2020 May 1. pii: JVI.00711-20. doi: 10.1128/JVI.00711.
PubMed Abstract available

April 2020

NGUYEN A, David JK, Maden SK, Wood MA, et al
Human leukocyte antigen susceptibility map for SARS-CoV-2.
J Virol. 2020 Apr 17. pii: JVI.00510-20. doi: 10.1128/JVI.00510.
PubMed Abstract available

WANG M, Li M, Ren R, Li L, et al
International expansion of a novel SARS-CoV-2 mutant.
J Virol. 2020 Apr 8. pii: JVI.00567-20. doi: 10.1128/JVI.00567.
PubMed Abstract available

LICASTRO D, Rajasekharan S, Dal Monego S, Segat L, et al
Isolation and full-length genome characterization of SARS-CoV-2 from COVID-19 cases in Northern Italy.
J Virol. 2020 Apr 1. pii: JVI.00543-20. doi: 10.1128/JVI.00543.
PubMed Abstract available

CAGLIANI R, Forni D, Clerici M, Sironi M, et al
Computational inference of selection underlying the evolution of the novel coronavirus, SARS-CoV-2.
J Virol. 2020 Apr 1. pii: JVI.00411-20. doi: 10.1128/JVI.00411.
PubMed Abstract available

January 2020

WAN Y, Shang J, Graham R, Baric RS, et al
Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS.
J Virol. 2020 Jan 29. pii: JVI.00127-20. doi: 10.1128/JVI.00127.
PubMed Abstract available

Thank you for your interest in scientific medicine.

AMEDEO COVID-19 is free of charge.